US 12,575,873 B2Grant
Method and apparatus for rapid and selective tissue ablation with cooling
Issue Date:2026-03-17
•12 Claims
•16 Drawing Sheets
Abstract
Systems, tools and methods are disclosed for the selective and rapid application of DC voltage to drive irreversible electroporation, with the system controller capable of being configured to apply voltages to independently selected subsets of electrodes and capable of generating at least one control signal to maintain the temperature near an electrode head within a desired range of values. Electrode clamp devices are also disclosed for generating electric fields to drive irreversible electroporation while modulating temperature to elevate the irreversible electroporation threshold utilizing a variety of means such as cooling fluid or solid state thermoelectric heat pumps.
Metadata
Assignee
- Boston Scientific Scimed, Inc.
Inventors
- Steven R. Mickelsen
- Raju Viswanathan
- Allan Zingeler
Application Information
Application Number:US 18/298,251
Filing Date:2023-04-10
Priority Date:2014-06-12
Art Unit:3794
Classifications
IPC:
A61B18/14A61B17/08A61B18/00A61B90/00
Field of Search:
A61B 18/14A61B 18/1442A61B 2018/00005A61B 2018/00464A61B 2018/00613A61B 2018/00779A61B 2018/00791A61B 2090/061
Patent Drawings (16 sheets)
Description
Cross-Reference to Related Applications
[0001] This application is a continuation of U.S. patent application Ser. No. 16/838,617 titled “METHOD AND APPARATUS FOR RAPID AND SELECTIVE TISSUE ABLATION WITH COOLING,” filed Apr. 2, 2020, now issued U.S. Pat. No. 11,622,803, which is a divisional of U.S. patent application Ser. No. 15/354,475 titled “METHOD AND APPARATUS FOR RAPID AND SELECTIVE TISSUE ABLATION WITH COOLING,” filed Nov. 17, 2016, now issued U.S. Pat. No. 10,624,693, which is a continuation of PCT Application No. PCT/US2015/035582 titled “METHOD AND APPARATUS FOR RAPID AND SELECTIVE TISSUE ABLATION WITH COOLING,” filed Jun. 12, 2015, which claims the benefit of priority to U.S. Provisional Application Ser. No. 61/997,869, titled “Methods and Apparatus for Rapid and Selective Tissue Ablation with Cooling,” filed Jun. 12, 2014, the entire disclosures of each of which are incorporated herein by reference in their entirety.
Background
[0002] The embodiments described herein relate generally to medical devices for therapeutic electrical energy delivery, and more particularly to systems and methods for delivering electrical energy in the context of ablating tissue rapidly and selectively by the application of suitably timed pulsed voltages that generate irreversible electroporation of cell membranes, in conjunction with the application of suitable regional cooling to enhance electroporation selectivity and efficacy.
[0003] In the past decade or two the technique of electroporation has advanced from the laboratory to clinical applications, while the effects of brief pulses of high voltages and large electric fields on tissue has been investigated for the past forty years or more. It has been known that the application of brief high DC voltages to tissue, thereby generating locally high electric fields typically in the range of hundreds of Volts/centimeter can disrupt cell membranes by generating pores in the cell membrane. While the precise mechanism of this electrically-driven pore generation or electroporation is not well understood, it is thought that the application of relatively large electric fields generates instabilities in the lipid bilayers in cell membranes, causing the occurrence of a distribution of local gaps or pores in the membrane. If the applied electric field at the membrane is larger than a threshold value, the electroporation is irreversible and the pores remain open, permitting exchange of material across the membrane and leading to apoptosis or cell death. Subsequently the tissue heals in a natural process.
[0004] Some known processes of adipose tissue reduction by freezing, also known as cryogenically induced lipolysis, can involve a significant length of therapy time. In contrast, the action of irreversible electroporation can be much more rapid. Some known tissue ablation methods employing irreversible electroporation, however, involve destroying a significant mass of tissue, and one concern the temperature increase in the tissue resulting from this ablation process.
[0005] While pulsed DC voltages are known to drive irreversible electroporation under the right circumstances, the examples of electroporation applications in medicine and delivery methods described in the prior art do not sufficiently discuss specificity and rapidity of action, or methods to treat a local region of tissue with irreversible electroporation while not applying electroporation to adjoining regions of tissue.
[0006] Thus, there is a need for selective energy delivery for electroporation and its modulation in various tissue types as well as pulses that permit rapid action and completion of therapy delivery. There is also a need for more effective generation of voltage pulses and control methods, as well as appropriate devices or tools addressing a variety of specific clinical applications. Such more selective and effective electroporation delivery methods can broaden the areas of clinical application of irreversible electroporation including therapeutic treatment to reduce the volume of adipose or fat tissue and the treatment of tumors of various types.
Summary
[0007] The embodiments described herein address the need for tools and methods for rapid and selective application of irreversible electroporation therapy as well as pulse generation and control methods. The process of irreversible electroporation can be induced even without the flow of current when a polarizing high voltage is applied to generate a suitably large electric field in a region of interest. The embodiments described herein can result in well-controlled and specific delivery of electroporation in an efficacious manner.
[0008] In some embodiments, an apparatus includes a clamp, a first electrode head and a second electrode head. The clamp includes a first arm and a second arm, each configured to exert opposing forces to maintain a target tissue disposed therebetween. The first electrode head is coupled to the first arm. The first electrode head includes a first electrically insulating contact surface, a first electrode and a first cooling unit. The first contact surface is configured to contact a first portion of the target tissue. The first cooling unit is configured to maintain the first portion of the target tissue at a first target temperature. The second electrode head is coupled to the second arm, and includes a second electrically insulating contact surface, a second electrode and a second cooling unit. The second contact surface is configured to contact a second portion of the target tissue. The second cooling unit is configured to maintain the second portion of the target tissue at a second target temperature. The first electrode and the second electrode are collectively configured to deliver a voltage pulse to the target tissue.
Brief Description of the Drawings
[0009] FIG. 1A is a schematic illustration of an irreversible electroporation system that includes a DC voltage/signal generator, a controller capable of being configured to apply voltages to selected subsets of electrodes, and one or more medical devices connected to the controller.
[0010] FIG. 1B is a schematic illustration of an irreversible electroporation system that includes a DC voltage/signal generator and a controller according to an embodiment.
[0011] FIG. 2 is a schematic illustration of a waveform generated by the irreversible electroporation system according to an embodiment, showing a balanced rectangular wave.
[0012] FIG. 3 is a schematic illustration of a waveform generated by the irreversible electroporation system according to an embodiment, showing a balanced biphasic rectangular wave.
[0013] FIG. 4 is a schematic illustration of a waveform generated by the irreversible electroporation system according to an embodiment, showing a progressive balanced biphasic rectangular wave.
[0014] FIG. 5 is a schematic illustration of a fat ablation electrode clamp device according to an embodiment, where an electrode system is schematically shown clamped around target tissue.
[0015] FIG. 6 is a schematic illustration of a fat ablation electrode clamp device according to an embodiment, where different parts of the electrode system are shown schematically.
[0016] FIG. 7 is a schematic illustration of a fat ablation electrode clamp device according to an embodiment, where multiple electrodes are shown on each clamp, the electrode heads incorporating means for solid state cooling, and including a means for adjusting the separation between electrode clamps.
[0017] FIG. 8 is a schematic illustration of an electrode head design according to an embodiment incorporating means for solid state cooling.
[0018] FIG. 9 is a schematic illustration of an individual thermoelectric cooling unit.
[0019] FIG. 10 is a schematic illustration of a thermoelectric cooling module according to an embodiment incorporating a multiplicity of thermoelectric cooling units.
[0020] FIG. 11 is a schematic illustration of electrode clamp device placement geometry in relation to patient anatomy, according to an embodiment.
[0021] FIG. 12 is a schematic illustration of an electrode clamp device according to an embodiment showing electrode heads with large aspect ratio.
[0022] FIG. 13 is a schematic illustration of electrode clamps according to an embodiment with large aspect ratio electrode heads showing overall placement geometry in relation to patient anatomy.
[0023] FIG. 14 is a schematic illustration of an electrode clamp device for irreversible electroporation according to an embodiment, further incorporating means for sensing separation or distance in the form of suitable sensors mounted away from the electrode heads.
[0024] FIG. 15 is a schematic illustration of an electrode clamp device for irreversible electroporation according to an embodiment, further incorporating means for sensing separation or distance in the form of suitable sensors mounted on the electrode heads.
Detailed Description
[0025] Medical systems, tools and methods are disclosed for the selective and rapid application of DC voltage to drive electroporation. In some embodiments, an apparatus includes a clamp, a first electrode head and a second electrode head. The clamp includes a first arm and a second arm, each configured to exert opposing forces to maintain a target tissue disposed therebetween. The first electrode head is coupled to the first arm. The first electrode head includes a first electrically insulating contact surface, a first electrode and a first cooling unit. The first contact surface is configured to contact a first portion of the target tissue. The first cooling unit is configured to maintain the first portion of the target tissue at a first target temperature. The second electrode head is coupled to the second arm, and includes a second electrically insulating contact surface, a second electrode and a second cooling unit. The second contact surface is configured to contact a second portion of the target tissue. The second cooling unit is configured to maintain the second portion of the target tissue at a second target temperature. The first electrode and the second electrode are collectively configured to deliver a voltage pulse to the target tissue.
[0026] In some embodiments, an apparatus includes a voltage pulse generator configured to produce a pulsed voltage waveform, and an electrode controller. The electrode controller is configured to be operably coupled to the voltage pulse generator and a medical clamp. The medical clamp includes a plurality of electrodes. The electrode controller is implemented in at least one of a memory or a processor, and includes a feedback module, a cooling module and a pulse delivery module. The feedback module is configured to determine a temperature of a target tissue to which the medical clamp is coupled. The cooling module is configured to produce a signal to a cooling unit of the medical clamp to maintain a portion of the target tissue at a target temperature. The pulse delivery module is configured to deliver an output signal associated with the pulsed voltage waveform to the plurality of electrodes.
[0027] In some embodiments, a non-transitory processor readable medium storing code representing instructions to be executed by a processor includes code to cause the processor to determine a temperature of a target tissue to which a medical clamp is coupled. The medical clamp includes a plurality of electrodes. The code further includes code to produce a signal based at least in part on the temperature of the target tissue. The signal is delivered to a cooling unit of the medical clamp to maintain a portion of the target tissue at a target temperature. The code further includes code to deliver an output signal associated with the pulsed voltage waveform to the plurality of electrodes when the target tissue is at the target temperature.
[0028] In some embodiments, a method includes receiving, at a feedback module of an electrode controller, a signal associated with a temperature of a target tissue to which a medical clamp is coupled. The medical clamp includes a plurality of electrodes. A signal based at least in part on the temperature of the target tissue is produced. The signal is then delivered to a cooling unit of the medical clamp to maintain a portion of the target tissue at a target temperature. The method includes delivering an output signal associated with the pulsed voltage waveform to the plurality of electrodes when the target tissue is at the target temperature.
[0029] In some embodiments, an irreversible electroporation system includes a DC voltage/signal generator and a controller capable of being configured to apply voltages to a selected multiplicity of electrodes. Further, the controller is capable of applying control inputs whereby selected pairs of anode-cathode subsets of electrodes can be sequentially updated based on a pre-determined sequence. In some embodiments, the controller can further receive at least one temperature input, and based on a temperature input the controller can modify or update a control parameter that can help to maintain a temperature value near a region of interest. The generator can output waveforms that can be selected to generate a sequence of voltage pulses in either monophasic or biphasic forms and with either constant or progressively changing amplitudes.
[0030] Devices are disclosed for the selective electroporation ablation of particular tissue type (e.g., adipose tissue) while preserving surrounding tissue of other types. In some embodiments, the system can include a means for sensing electrode separation, and the electrode voltage applied can be determined based on a sensed separation or distance measure. This determination can be fully or partially automatic, or manual.
[0031] In some embodiments, a system uses temperature to selectively ablate tissue as the threshold of irreversible electroporation is temperature-dependent, utilizing means such as the suitable use of cooling fluid or solid state cooling methods to locally raise the irreversible electroporation threshold electric field value and thereby selecting the predominant tissue type or region it is desired to ablate. In contrast to the process of adipose tissue reduction by freezing, also known as cryogenically induced lipolysis, which uses lower temperatures to directly freeze adipose tissue, the lowered temperatures according to an embodiment assist in the selective action of irreversible electroporation, a much more rapid process than freezing.
[0032] In some embodiments, an irreversible electroporation system includes a DC voltage/signal generator and a controller that is configured to apply voltages to a selected multiplicity or a subset of electrodes. In some embodiments, a temperature measurement device such as a thermistor measures temperature at or near a portion of an electrode device. The controller is capable of applying control inputs whereby the temperature at or near a portion of the device is maintained within a narrow range of desired values. Preferably, the temperature at or near an electrode or electrode head surface contacting a patient anatomy is maintained at or near a value that is lower than body temperature. In some embodiments, the application of DC voltage pulses is made only when the temperature is within a narrow range of values around a desired value. In some embodiments, at least one control input for temperature control takes the form of rate of flow of a cooling fluid, while in another embodiment, the control input is a voltage that drives a thermoelectric heat pump. Further, in some embodiments, the electrode clamp device disclosed here incorporates a sensor to measure a separation distance, based on which the electroporation voltage value is selected.
[0033] A DC voltage for electroporation can be applied to subsets of electrodes identified as anode and cathode respectively on opposite sides of an anatomical region it is desired to ablate. The DC voltage is applied in brief pulses sufficient to cause irreversible electroporation and can preferably be in the range of 0.5 kV to 60 KV and more preferably in the range 1 kV to 10 kV, so that an appropriate threshold electric field value of at least around 800 Volts/cm is effectively achieved in the tissue (for example, adipose tissue) to be ablated. In some embodiments, the DC voltage generator setting for irreversible electroporation is automatically identified by the electroporation system based on a sensed distance measuring the spatial separation between electrodes of opposing polarities. In an alternate embodiment, the DC voltage value is selected directly by a user from a suitable dial, slider, touch screen, or any other user interface. In some embodiments, while transient currents may be induced in the tissue upon voltage application or removal, there are no other (steady state) currents as the electrodes are insulated from the subject anatomy. A region or volume of tissue where the electric field is sufficiently large for irreversible electroporation to occur is ablated during the DC voltage pulse application. At the same time, the application of surface cooling raises the electroporation threshold of tissue near the surface and prevents the occurrence of irreversible electroporation in this surface layer.
[0034] As used in this specification, the singular forms “a,” “an” and “the” include plural referents unless the context clearly dictates otherwise. Thus, for example, the term “a member” is intended to mean a single member or a combination of members, “a material” is intended to mean one or more materials, “a processor” is intended to mean a single processor or multiple processors; and “memory” is intended to mean one or more memories, or a combination thereof.
[0035] As used herein, the terms “about” and “approximately” generally mean plus or minus 10% of the value stated. For example, about 0.5 would include 0.45 and 0.55, about 10 would include 9 to 11, about 1000 would include 900 to 1100.
[0036] A schematic diagram of the electroporation system according to an embodiment is shown in FIG. 1A . The system includes a DC voltage/signal generator 23 is driven by a controller unit 21 that interfaces with a computer device 24 by means of a two-way communication link 29. The controller can perform channel selection and routing functions for applying DC voltages to appropriate electrodes that have been selected by a user or by the computer 24, and apply the voltages via a multiplicity of leads (shown collectively as 26) to an electrode device 22. The electrode device 22, and any of the electrode devices described herein can be similar to the ablation catheters described in PCT Publication No. WO2014/025394, entitled “Catheters, Catheter Systems, and Methods for Puncturing Through a Tissue Structure,” filed on Mar. 14, 2013 (“the '394 PCT Application), which is incorporated herein by reference in its entirety.
[0037] Some of the leads 26 from the controller 21 can also carry control signals to adjust temperature at or near the electrode device. In an alternate embodiment, the control signals from the controller 21 can be routed to a different unit (not shown) such as a cooling pump for example, to control cooling fluid flow rate). The electrode device 22 can also send information and/or signals to the controller 21, such as temperature data from sensors mounted on or near the electrode device. Such feedback signals are indicated by the data stream 25, which can be sent via separate leads. While the DC voltage generator 23 sends a DC voltage to the controller 21 through leads 27, the voltage generator is driven by control and timing inputs 28 from the controller unit 21.
[0038] In some embodiments, the electrode controller can include one or more modules and can automatically control the temperature of a target tissue, adjust a characteristic of the voltage waveform based on the spacing between adjacent electrodes, or the like. For example, FIG. 1B shows an electroporation system according to an embodiment that includes an electrode controller 900 and a signal generator 925. The electrode controller 900 is coupled to a computer 920 or other input/output device, and is configured to be operably coupled to a medical device 930. The medical device 930 can be one or more of the medical clamps of the types shown and described herein. Further the medical device 930 can be coupled to, disposed about and/or in contact with a target tissue T. In this manner, as described herein, the electroporation system, including the electrode controller 900 and the signal generator 925, can deliver voltage pulses to the target tissue for therapeutic purposes.
[0039] The controller 900 can include a memory 911, a processor 910, and an input/output module (or interface) 901. The controller 900 can also include a temperature control module 902, a feedback module 905, and a pulse delivery module 908. The electrode controller 900 is coupled to a computer 920 or other input/output device via the input/output module (or interface) 901.
[0040] The processor 910 can be any processor configured to, for example, write data into and read data from the memory 911, and execute the instructions and/or methods stored within the memory 911. Furthermore, the processor 910 can be configured to control operation of the other modules within the controller (e.g., the temperature control module 902, the feedback module 905, and the pulse delivery module 908). Specifically, the processor 910 can receive a signal including user input, temperature data, distance measurements or the like and determine a set of electrodes to which voltage pulses should be applied, the desired timing and sequence of the voltage pulses and the like. In other embodiments, the processor 910 can be, for example, an application-specific integrated circuit (ASIC) or a combination of ASICs, which are designed to perform one or more specific functions. In yet other embodiments, the microprocessor can be an analog or digital circuit, or a combination of multiple circuits.
[0041] The memory device 911 can be any suitable device such as, for example, a read only memory (ROM) component, a random access memory (RAM) component, electronically programmable read only memory (EPROM), erasable electronically programmable read only memory (EEPROM), registers, cache memory, and/or flash memory. Any of the modules (the temperature control module 902, the feedback module 905, and the pulse delivery module 908) can be implemented by the processor 910 and/or stored within the memory 911.
[0042] As shown, the electrode controller 900 operably coupled to the signal generator 925. The signal generator includes circuitry, components and/or code to produce a series of DC voltage pulses for delivery to electrodes included within the medical device 930. For example, in some embodiments, the signal generator 925 can be configured to produce a biphasic waveform having a pre-polarizing pulse followed by a polarizing pulse. The signal generator 925 can be any suitable signal generator of the types shown and described herein.
[0043] The pulse delivery module 908 of the electrode controller 900 includes circuitry, components and/or code to deliver an output signal associated with the pulsed voltage waveform produced by the signal generator 925. This signal (shown as signal 909) can be any signal of the types shown and described herein, and can be of a type and/or have characteristics to be therapeutically effective. In some embodiments, the pulse delivery module 908 receives input from other portions of the system, and can therefore send the signal 909 to the appropriate subset of electrodes, as described herein.
[0044] The electrode controller 900 includes the temperature control module 902. The temperature control module 902 includes circuitry, components and/or code to produce a control signal (identified as signal 903) that can be delivered to the cooling unit (not shown) of the medical device 930 to facilitate cooling of a portion of the tissue T.
[0045] In some embodiments, the ablation controller and signal generator can be mounted on a rolling trolley, and the user can control the device using a touchscreen interface that could possibly be in the sterile field. The touchscreen can be for example an LCD touchscreen in a plastic housing mountable to a standard medical rail or post and can be used to select the electrodes for ablation and to ready the device to fire. The interface can for example be covered with a clear sterile plastic drape. The operator can select the electrodes involved in an automated sequence, if any. The touch screen graphically shows the catheters that are attached to the controller. In one embodiment the operator can select electrodes from the touchscreen with appropriate graphical buttons. The ablation sequence can be initiated by holding down a hand-held trigger button that is possibly in a sterile field. The hand-held trigger button can be illuminated red to indicate that the device is “armed” and ready to ablate. The trigger button can be compatible for use in a sterile field and when attached to the controller can be illuminated a different color, for example white. In some embodiments, the “armed” state of the trigger can depend on whether the electrode temperature is within a desired range of values; if not, an appropriate control signal is applied to bring the temperature back to the desired range. When the device is firing, the trigger button flashes in sequence with the pulse delivery in a specific color such as red. The waveform of each delivered pulse is displayed on the touchscreen interface.
[0046] The waveforms for the various electrodes can be displayed and recorded on the case monitor and simultaneously outputted to a standard data acquisition system. With the high voltages involved with the device, the outputs to the data acquisition system are protected from voltage and/or current surges. The waveform amplitude, period, duty cycle, and delay can all be modified, for example via a suitable Ethernet connection.
[0047] In some embodiments, a system (generator and controller) according to an embodiment can deliver rectangular-wave pulses with a peak maximum voltage of up to about 10 kV into a load with an impedance in the range of 30 Ohm to 3000 Ohm for a maximum duration of 200 μs. In some embodiments the maximum duration can be 100 μs. The load can be part of the electrode circuitry, so that power is harmlessly dissipated in the load. Pulses can be delivered in a multiplexed and synchronized manner to a multi-electrode device with a duty cycle of up to 50% (for short bursts). The pulses can generally be delivered in bursts, such as for example a sequence of between 2 and 10 pulses interrupted by pauses of between 1 ms and 1000 ms. In one embodiment, the multiplexer controller is capable of running an automated sequence to deliver the impulses/impulse trains (from the DC voltage signal/impulse generator) to the tissue target as a sequence of pulses over electrodes. The controller system is capable of switching between subsets of electrodes located on the electrode device.
[0048] In some embodiments, the controller can have several pulse sequence configurations that provide the operator with at least some variety of programming options. In one configuration, the controller can switch electrode configurations of a bipolar set of electrodes (cathode and anode) sequentially along the length of an electrode clamp device. The user can control the application of DC voltage with a single handheld switch. A sterile catheter or catheters can be connected to the voltage output of the generator via a connector cable. In one embodiment, the user activates the device with a touch screen. The generator can remain in a standby mode until the user is ready to apply pulses at which point the user/assistant can put the generator into a ready mode via the touchscreen interface. Subsequently the user can select the sequence and the active electrodes.
[0049] In some embodiments, any of the systems described herein can select an appropriate voltage value based on a distance measurement between electrodes of opposing polarities. In this manner, the system can ensure that an electric field sufficient to cause irreversible electroporation is applied up to the desired depth.
[0050] The controller and generator can output waveforms that can be selected to generate a sequence of voltage pulses in either monophasic or biphasic forms and with either constant or progressively changing amplitudes. FIG. 2 shows a square or rectangular wave pulse train where the pulses 101 have a uniform height or maximum voltage. FIG. 3 shows an example of a balanced biphasic rectangular pulse train, where each positive voltage pulse such as 103 is immediately followed by a negative voltage pulse such as 104 of equal amplitude and opposite sign. While in this example the biphasic pulses are balanced with equal amplitudes of the positive and negative voltages, in other embodiments an unbalanced biphasic waveform could also be used as may be convenient for a given application.
[0051] A train of multiple DC voltage pulses can be applied to ensure that sufficient tissue ablation has occurred. Further, the user can repeat the delivery of irreversible electroporation over several successive pulse trains for further confidence.
[0052] Yet another example of a waveform or pulse shape that can be generated by any of the systems described herein is illustrated in FIG. 4 , which shows a progressive balanced rectangular pulse train. In this pulse train, each distinct biphasic pulse has equal-amplitude positive and negative voltages, but each pulse such as 107 is larger in amplitude than its immediate predecessor 106. Other variations such as a progressive unbalanced rectangular pulse train, or indeed a wide variety of other variations of pulse amplitude with respect to time can be conceived and implemented by those skilled in the art based on the teachings herein.
[0053] The time duration of each irreversible electroporation rectangular voltage pulse could lie in the range from 1 nanosecond to 10 milliseconds, with the range 10 microseconds to 1 millisecond being more preferable and the range 50 microseconds to 300 microseconds being still more preferable. The time interval between successive pulses of a pulse train could be in the range of 10 microseconds to 1 millisecond, with the range 50 microseconds to 300 microseconds being more preferable. The number of pulses applied in a single pulse train (with delays between individual pulses lying in the ranges just mentioned) can range from 1 to 100, with the range 1 to 10 being more preferable. As described in the foregoing, a pulse train can be driven by a user-controlled switch or button, in one embodiment preferably mounted on a hand-held joystick-like device. In one mode of operation a pulse train can be generated for every push of such a control button, while in an alternate mode of operation pulse trains can be generated repeatedly during the refractory periods of a set of successive cardiac cycles, for as long as the user-controlled switch or button is engaged by the user.
[0054] All of these parameters can be determined by the design of the signal generator, and in various embodiments could also be determined by user control as may be convenient for a given clinical application. The specific examples and descriptions herein are exemplary in nature and variations can be developed by those skilled in the art based on the material taught herein without departing from the scope according to an embodiment, which is limited only by the attached claims.
[0055] In some embodiments, an irreversible electroporation ablation system of the type shown and described herein can be used for adipose tissue (or fat) ablation for the reduction or elimination of adipose tissue. As mentioned earlier, various tissue or cell types have different irreversible electroporation thresholds. Fat cells typically have an irreversible electroporation threshold in the range of 800 Volts/cm. FIG. 5 shows an electrode clamp device that externally clamps onto a fold of skin on a patient anatomy, with electrode clamp arms 211 connected to a clamp head 210 including springs, screw or other tightening mechanisms for firmly positioning the electrodes in a clamped position. The electrode clamp arms end in electrode heads 212 that incorporate cooling coils 219 that carry a cooling fluid at a temperature sufficient to cool and maintain the skin temperature at about approximately 50 degrees Fahrenheit. A cooling system and drive pump (not shown) with a controllable fluid flow rate supply coolant to maintain the electrode temperature at or near a suitably low value (such as, for example, 50 degrees Fahrenheit). The electrodes are shown clamping on to tissue in the form of a layer of skin 215 with fatty tissue 214 beneath the skin. Each electrode itself is located internally within its electrode head and the latter is made of insulating material, so that no conductor touches the patient surface. FIG. 5 shows an example of electric field lines 217 generated in the tissue when a DC voltage is applied across the electrodes.
[0056] As shown in FIG. 5 , since the patient-contacting surfaces are insulators, there is no steady state charge transfer or direct current within the tissue. However, the polarizing electric field applied in pulses can generate irreversible electroporation in the tissue and generate induced or transient currents in the tissue. The irreversible electroporation threshold of tissue increases as temperature decreases. Thus, by cooling the electrodes and the layer of skin, the skin tissue's electroporation threshold can be increased beyond the approximately 800 V/cm threshold value of fat tissue. When a DC electric field of suitable strength is applied, fat (indicated by 214 in FIG. 5 ) can therefore be selectively ablated by electroporation while maintaining the integrity of skin tissue (indicated by 215 in FIG. 5 ) as long as the applied electric field is in the range between the irreversible electroporation thresholds of adipose tissue and the cooled skin tissue.
[0057] FIG. 6 is a schematic illustration of an electrode head of the electrode clamp device showing the electrodes or electroporation probes 233 situated within an outer casing 231. Coolant coils 235 within each electrode head keep the electrode head surface cold and maintain the skin temperature at approximately 50 degrees Fahrenheit. The patient-contacting surface 239 of each electrode head is an insulator, so that there is no direct current transfer between the electrodes. The parallel electrodes act like capacitor plates for very brief periods as DC voltage pulses are applied for irreversible electroporation. The electric field 237 generated between the electrodes in the tissue region serves to polarize the tissue and generate irreversible electroporation in the fat or adipose tissue. The voltage pulses induce brief transient currents in the tissue when the field changes but no steady state direct current. Thus with this device, inductive irreversible electroporation can be generated. The applied DC voltage can be made to depend on the distance between the electrodes. In one embodiment, the electrode clamp can have a discrete number of possible relative positions of the electrodes with pre-determined separation distances. Based on the separation, a sufficient voltage that generates at least an approximately 800 Volts/cm electric field between the electrodes can be computed by the electroporation system and applied for the selective irreversible electroporation of adipose tissue.
[0058] FIG. 7 shows an electrode clamp device that externally clamps onto a fold of skin on a patient anatomy, with electrode clamp arms 301 and 302 connected to a clamp head 314 including a screw mechanism 319 for firmly positioning the electrodes in a clamped position around a portion of patient anatomy, with a fixed distance between electrode arms. The top electrode arm 301 has disposed along it electrode heads 305, 306 and 307 respectively aligned with electrode heads 315, 316 and 317 on the bottom electrode arm 302. In FIG. 7 , the lower electrode arm 302 is fixed to a mount (not shown) and the screw mechanism allows for the vertical motion of electrode arm 301 relative to electrode arm 302, thereby permitting adjustment of the separation distance between the arms over a range of values. In some embodiments, the electrode heads can incorporate thermoelectric cooling modules for keeping the patient-contacting face of each electrode at a cooled temperature significantly below body temperature (for example, the patient contacting face of the electrode can be maintained in a narrow range around 50 degrees Fahrenheit). This can be done with a thermoelectric or solid state cooling module by applying an appropriate voltage or current to the cooling module. Solid state cooling has the advantage of having no moving parts with corresponding convenience of design and implementation.
[0059] As an example, referring to FIG. 7 bipolar leads 310, 311 and 312 attach to electrode heads 305, 306 and 307 respectively in order to control the temperature on the patient contacting electrode face of each electrode. When an appropriate voltage is applied across a Peltier cooling module, it functions as a heat pump, transferring heat from one face of the module to the other. Furthermore, each electrode head, or at least each electrode arm, can incorporate a temperature sensing unit such as a thermistor 297 shown attached to leads 298 on electrode arm 302. The data from the temperature sensing unit is read by the controller (not shown in FIG. 7 ) or to a computer where the temperature data is utilized to generate an appropriate control signal for the purpose of maintaining electrode face temperature by using any of a range of control schemes or methods, for example PID (Proportional-Integral-Derivative) control.
[0060] FIG. 8 is a schematic illustration of an electrode head incorporating means for solid state or thermoelectric cooling. A metal electrode 332 for high voltage DC application abuts a ceramic cover 333 on one side (with the outside face of the ceramic cover being a patient contacting face) and a thermoelectric or Peltier cooling module 331 on the other. The top face of the cooling module 331 is adjacent to a ceramic cover 330, so that the entire electrode head has ceramic faces on both top and bottom faces.
[0061] FIG. 9 schematically illustrates a thermoelectric or Peltier cooling unit, a multiplicity of which can be arranged to form a Peltier cooling module. The thermoelectric unit comprises a p-type semiconductor 401 (such as for example Lead Telluride) electrically in series with an n-type semiconductor 402 (such as for example Bismuth Telluride) and connected by a metallic connection 404. At the same time, the semiconductors 401 and 402 are thermally connected in parallel. The disjoint ends of the p-type semiconductor and the n-type semiconductor are connected to metallic terminal electrodes 406 and 407 respectively with negative and positive electric polarities or voltages respectively, and the electrodes 406 and 407 abut a ceramic cover 408. When a voltage is applied to the terminal electrodes (so that terminal 406 is at a negative electric potential relative to terminal 407), a current flows from the n-type semiconductor 402 through the series connection 404 and through the p-type semiconductor 401. The respective charge carriers in each semiconductor move from the top to the bottom, and correspondingly there is a heat flux that transports heat from the top face 404 of the Peltier cooling unit to the bottom face 408. Correspondingly 404 is turned into the “cold” or lower temperature face and 408 into the “hot” or higher temperature face of the Peltier cooling unit.
[0062] FIG. 10 schematically depicts a chain of Peltier cooling units connected to form a thermoelectric cooling module. In this example, the module 453 comprises Peltier cooling units 458, 459, 460, 461, 462, 463, 464 and 465 connected in a chain so as to spread approximately uniformly over an area and such that all the units have for example a “hot side” on the bottom and a “cold” side on the top. An appropriate voltage can be applied across the end terminal leads 455 and 456 in order to drive a heat flux between the top and bottom sides and maintain a cold surface.
[0063] Thermoelectric heat pump modules are commercially available, for example from sources such as TE Technology, Inc. of Traverse City, Michigan, USA and appropriate configurations convenient for the electrode clamp devices according to an embodiment can be arrived at by those skilled in the art.
[0064] FIG. 11 schematically illustrates one geometry of use of the electrode clamp device, wherein a portion 347 of skin and adipose tissue 342 disposed around a patient anatomy 341 is clamped between electrode arms 344 and 345 for electroporation ablation. FIG. 12 is an illustration of an electrode clamp device with electrode arms 301 and 302 wherein their respective electrode heads 326 and 327 are longitudinally disposed and have large aspect ratios, as shown schematically therein. As shown in the geometry depicted schematically in FIG. 13 , such an arrangement could be used to clamp, in a lengthwise disposition, a portion of skin and adipose tissue 342 disposed around a patient anatomy 341 between electrode arms 344 and 345 for electroporation ablation.
[0065] In some embodiments, the time for which a cold temperature is maintained at the patient contacting surface of the electrode head is monitored and varied, so that the cooling control is applied in time in a pulse-like format. This is done in order to maintain a surface layer of tissue at a suitably low or cold temperature, while ensuring that deeper regions of tissue undergo no more than marginal cooling. The thermal diffusivity D of skin tissue is known to be in the range of 0.11 mm2/s. From standard heat diffusion theory, in a time T the depth x to which a temperature change applied at the surface is propagated is given (in two dimensions) by x 2DT; in 20 seconds of cooling, we have x−2 mm, about the thickness of skin tissue. In one mode of operation of the system according to an embodiment, the cooling of the electrodes is performed in discrete time intervals in the range of 10 seconds to 40 seconds, followed by a pulse train application, the entire duration of the pulse train being in the range of less than about 8 seconds. Thus, the application of cooling could also be performed in pulses. The next ablation in the same tissue region is performed, if necessary, after another cooling pulse is applied over a discrete time interval, and so on. In some embodiments, a heating pulse could follow a cooling pulse in order to ensure that the temperature in the interior of the tissue does not fall below a threshold value. Such a heating pulse can be applied when a thermoelectric or Peltier heat pump is used simply by reversing the polarity of the (voltage) control signal to the heat pump, and the heating pulse could have a duration in the range between 2 and 30 seconds.
[0066] FIG. 14 illustrates schematically one embodiment, where the electrode clamp device with electrode arms 301 and 302 with respective electrode heads 305 and 35 further has a sensor for measuring separation distance, in the form of an electromagnetic transmitter 352 on electrode arm 302 and an electromagnetic receiver coil 350 on electrode arm 301. Leads 354 and 355 respectively connect to receiver 350 and transmitter 352. Based on the signal intensity received by the receiver 350, the distance of separation d indicated by 355 in the FIG. can be measured. For example, if the axes and centers of the transmitter and receiver sensors are aligned, and a current/flows through the transmitter (of radius a), the magnetic field B at the center of the receiver is given by
[0067]
where μo is the magnetic permeability of free space. If the current in the transmitter is sinusoidal with circular frequency co, the time varying magnetic field induces a voltage in the receiver given to a good approximation by
where μo is the magnetic permeability of free space. If the current in the transmitter is sinusoidal with circular frequency co, the time varying magnetic field induces a voltage in the receiver given to a good approximation by
[0068]
where A is the area of the receiver. Thus by measuring the induced voltage V, the separation distance d can be determined.
where A is the area of the receiver. Thus by measuring the induced voltage V, the separation distance d can be determined.
[0069] While in FIG. 14 the transmitter and receiver sensors for distance determination were located at a separation away from the electrode heads to mitigate electromagnetic interference with the metallic electrodes, in an alternate embodiment, the transmitter and receiver sensors could be integrated within an electrode head, as shown schematically in FIG. 15 . In FIG. 15 , the transmitter 352 is incorporated in electrode head 315 of lower electrode arm 302, while receiver sensor 350 is incorporated in electrode head 305 of upper electrode arm 301. Also shown are other electrode heads 306, 307, 316 and 317. With this arrangement, the induced voltage at the receiver is calibrated over a range of separations of the electrode arms, in effect generating a lookup table. The electromagnetic interference of the electrode heads is implicitly accounted for by this calibration process; subsequently, given a measured induced voltage at the receiver, the separation distance can be determined from the calibration data.
[0070] While the foregoing described one method of separation distance determination based on an electromagnetic scheme purely for illustrative and exemplary purposes, it should be apparent that a variety of other methods are available for this purpose such as for example schemes based on the use of ultrasound transmitters and receivers or infrared transmitters and receivers. Based on the teachings herein, those skilled in the art could arrive at an implementation that may be convenient for a specific application.
[0071] With a separation distance between electrode heads thus determined, the applied voltage to the electrode heads is then correspondingly determined based on a desired irreversible electroporation threshold value. For example, if the distance between electrode heads is measured to be 4 cm, and the desired irreversible electroporation threshold value is an electric field of 800 Volts/cm, it is clear that a voltage of at least 3.2 kV (desired electric field times distance) needs to be applied between the electrodes in order to meet or exceed the threshold value for irreversible electroporation.
[0072] Some embodiments described herein relate to a computer storage product with a non-transitory computer-readable medium (also can be referred to as a non-transitory processor-readable medium) having instructions or computer code thereon for performing various computer-implemented operations. The computer-readable medium (or processor-readable medium) is non-transitory in the sense that it does not include transitory propagating signals per se (e.g., a propagating electromagnetic wave carrying information on a transmission medium such as space or a cable). The media and computer code (also can be referred to as code) may be those designed and constructed for the specific purpose or purposes. Examples of non-transitory computer-readable media include, but are not limited to: magnetic storage media such as hard disks, floppy disks, and magnetic tape; optical storage media such as Compact Disc/Digital Video Discs (CD/DVDs), Compact Disc-Read Only Memories (CD-ROMs), and holographic devices; magneto-optical storage media such as optical disks; carrier wave signal processing modules; and hardware devices that are specially configured to store and execute program code, such as Application-Specific Integrated Circuits (ASICs), Programmable Logic Devices (PLDs), Read-Only Memory (ROM) and Random-Access Memory (RAM) devices.
[0073] Examples of computer code include, but are not limited to, micro-code or micro-instructions, machine instructions, such as produced by a compiler, code used to produce a web service, and files containing higher-level instructions that are executed by a computer using an interpreter. For example, embodiments may be implemented using imperative programming languages (e.g., C, Fortran, etc.), functional programming languages (Haskell, Erlang, etc.), logical programming languages (e.g., Prolog), object-oriented programming languages (e.g., Java, C++, etc.) or other suitable programming languages and/or development tools. Additional examples of computer code include, but are not limited to, control signals, encrypted code, and compressed code.
[0074] While various specific examples and embodiments of systems and tools for selective tissue ablation with irreversible electroporation were described in the foregoing for illustrative and exemplary purposes, it should be clear that a wide variety of variations and alternate embodiments could be conceived or constructed by those skilled in the art based on the teachings according to an embodiment. While specific methods of control and DC voltage application from a generator capable of selective excitation of sets of electrodes were disclosed together with temperature control, persons skilled in the art would recognize that any of a wide variety of other control or user input methods can be implemented without departing from the scope according to an embodiment. Likewise, while the foregoing described a range of specific tools or devices for more effective and selective DC voltage application for irreversible electroporation through an externally applied electrode clamp device, other device constructions or variations could be implemented by one skilled in the art by employing the principles and teachings disclosed herein without departing from the scope according to an embodiment, in the treatment of excessive adipose tissue, tumor ablation, or a variety of other medical applications.
[0075] Furthermore, while the present disclosure describes specific embodiments and tools involving the use of temperature to selectively ablate tissue by taking advantage of the temperature-dependence of the threshold of irreversible electroporation and the application of specific cooling methodologies for exemplary purposes, it should be clear to one skilled in the art that a variety of methods and devices for fluid pumping and control, for tissue or electrode cooling, or even for tissue heating through the delivery of focused kinetic energy or electromagnetic radiation could be implemented utilizing the methods and principles taught herein without departing from the scope according to an embodiment.
[0076] Accordingly, while many variations of methods and tools disclosed here can be constructed, the scope according to an embodiment is limited only by the appended claims.
Claims
What is claimed is:
1. An apparatus, comprising:
a thermoelectric cooling unit comprising:
a first ceramic cover;
a metal electrode abutting the first ceramic cover;
a Peltier cooling module abutting the metal electrode; and
a second ceramic cover abutting the Peltier cooling module;
a voltage pulse generator configured to produce a pulsed voltage waveform; and
an electrode controller configured to be operably coupled to the voltage pulse generator and a medical clamp including a plurality of electrodes, the electrode controller implemented in at least one of a memory or a processor, the electrode controller including a feedback module, a cooling module and a pulse delivery module, the feedback module configured to determine a temperature of a target tissue to which the medical clamp is coupled, the cooling module configured to produce a signal to the cooling unit of the medical clamp to maintain a portion of the target tissue at a target temperature, the pulse delivery module configured to deliver an output signal associated with the pulsed voltage waveform to the plurality of electrodes.
2. The apparatus of claim 1, wherein the target temperature is below a body temperature.
3. The apparatus of claim 1, wherein the target temperature is below about 55 degrees Fahrenheit.
4. The apparatus of claim 1, wherein the electrode controller is configured to interface with an external device to program at least one of an amplitude of the output signal, a period of the output signal, or a duration of the output signal.
5. The apparatus of claim 1, wherein the cooling module is configured to produce the signal based at least in part on the temperature of the target tissue.
6. The apparatus of claim 1, wherein:
the medical clamp includes a first arm and a second arm, the first arm and the second arm defining a volume to receive the target tissue, the first arm spaced apart from the second arm by a distance;
the feedback module is configured to receive a distance signal associated with the distance; and
the pulse delivery module configured to adjust a characteristic of the output signal based on the distance.
7. The apparatus of claim 6, wherein the characteristic of the output signal is any one of an amplitude of the output signal, a period of the output signal, or duration of the output signal.
8. A method, comprising:
receiving, at a feedback module of an electrode controller, a temperature signal associated with a temperature of a target tissue to which a medical clamp is coupled, the medical clamp including a plurality of electrodes abutting a plurality of first ceramic covers and a first arm and a second arm defining a volume to receive the target tissue, the first arm spaced apart from the second arm by a distance;
producing a control signal based at least in part on the temperature of the target tissue;
delivering the control signal to a cooling unit of the medical clamp to maintain a portion of the target tissue at a target temperature, wherein the cooling unit abuts at least one of the plurality of electrodes and at least one of a plurality of second ceramic covers;
receiving a distance signal associated with the distance;
adjusting a characteristic of the output signal based on the distance; and
delivering an output signal associated with a pulsed voltage waveform to the plurality of electrodes when the target tissue is at the target temperature;
wherein the delivering the output signal is such that the pulsed voltage waveform is greater than approximately one kilovolt.
9. A method, comprising:
receiving, at a feedback module of an electrode controller, a temperature signal associated with a temperature of a target tissue to which a medical clamp is coupled, the medical clamp including a plurality of electrodes abutting a plurality of first ceramic covers, wherein the medical clamp includes a first arm and a second arm, the first arm and the second arm defining a volume to receive the target tissue, the first arm spaced apart from the second arm by a distance;
producing a control signal based at least in part on the temperature of the target tissue;
delivering the control signal to a cooling unit of the medical clamp to maintain a portion of the target tissue at a target temperature, wherein the cooling unit abuts at least one of the plurality of electrodes and at least one of a plurality of second ceramic covers;
receiving a distance signal associated with the distance;
adjusting a characteristic of an output signal based on the distance; and
delivering the output signal associated with a pulsed voltage waveform to the plurality of electrodes when the target tissue is at the target temperature.
10. The method of claim 9, wherein the target temperature of the target tissue is maintained below a body temperature.
11. The method of claim 9, wherein the target temperature of the target tissue is maintained below about 55 degrees Fahrenheit.
12. The method of claim 9, wherein the control signal controls a current to a thermoelectric cooler.
Patent Citations (773)
| Patent | Date | Inventor | Cited By |
|---|---|---|---|
| US4200104(A) | 1980-04-01 | Harris | Applicant |
| US4470407(A) | 1984-09-01 | Hussein | Applicant |
| US4739759(A) | 1988-04-01 | Rexroth et al. | Applicant |
| US5234004(A) | 1993-08-01 | Hascoet et al. | Applicant |
| US5242441(A) | 1993-09-01 | Avitall | Applicant |
| US5257635(A) | 1993-11-01 | Langberg | Applicant |
| US5281213(A) | 1994-01-01 | Milder et al. | Applicant |
| US5304214(A) | 1994-04-01 | Deford et al. | Applicant |
| US5306296(A) | 1994-04-01 | Wright et al. | Applicant |
| US5334193(A) | 1994-08-01 | Nardella | Applicant |
| US5341807(A) | 1994-08-01 | Nardella | Applicant |
| US5342301(A) | 1994-08-01 | Saab | Applicant |
| US5398683(A) | 1995-03-01 | Edwards et al. | Applicant |
| US5443463(A) | 1995-08-01 | Stern et al. | Applicant |
| US5454370(A) | 1995-10-01 | Avitall | Applicant |
| US5515848(A) | 1996-05-01 | Corbett et al. | Applicant |
| US5531685(A) | 1996-07-01 | Hemmer et al. | Applicant |
| US5545161(A) | 1996-08-01 | Imran | Applicant |
| US5578040(A) | 1996-11-01 | Smith | Applicant |
| US5617854(A) | 1997-04-01 | Munsif | Applicant |
| US5624430(A) | 1997-04-01 | Eton et al. | Applicant |
| US5667491(A) | 1997-09-01 | Pliquett et al. | Applicant |
| US5672170(A) | 1997-09-01 | Cho et al. | Applicant |
| US5700243(A) | 1997-12-01 | Narciso, Jr. | Applicant |
| US5702438(A) | 1997-12-01 | Avitall | Applicant |
| US5706823(A) | 1998-01-01 | Wodlinger | Applicant |
| US5722400(A) | 1998-03-01 | Ockuly et al. | Applicant |
| US5722402(A) | 1998-03-01 | Swanson et al. | Applicant |
| US5749914(A) | 1998-05-01 | Janssen | Applicant |
| US5779699(A) | 1998-07-01 | Lipson | Applicant |
| US5788692(A) | 1998-08-01 | Campbell et al. | Applicant |
| US5810762(A) | 1998-09-01 | Hofmann | Applicant |
| US5833710(A) | 1998-11-01 | Jacobson | Applicant |
| US5836874(A) | 1998-11-01 | Swanson et al. | Applicant |
| US5836942(A) | 1998-11-01 | Netherly et al. | Applicant |
| US5836947(A) | 1998-11-01 | Fleischman et al. | Applicant |
| US5843154(A) | 1998-12-01 | Osypka | Applicant |
| US5849028(A) | 1998-12-01 | Chen | Applicant |
| US5863291(A) | 1999-01-01 | Schaer | Applicant |
| US5868736(A) | 1999-02-01 | Swanson et al. | Applicant |
| US5871523(A) | 1999-02-01 | Fleischman et al. | Applicant |
| US5876336(A) | 1999-03-01 | Swanson et al. | Applicant |
| US5885278(A) | 1999-03-01 | Fleischman | Applicant |
| US5895404(A) | 1999-04-01 | Ruiz | Applicant |
| US5899917(A) | 1999-05-01 | Edwards et al. | Applicant |
| US5904709(A) | 1999-05-01 | Arndt et al. | Applicant |
| US5913854(A) | 1999-06-01 | Maguire et al. | Applicant |
| US5916158(A) | 1999-06-01 | Webster, Jr. | Applicant |
| US5916213(A) | 1999-06-01 | Haissaguerre et al. | Applicant |
| US5921924(A) | 1999-07-01 | Avitall | Applicant |
| US5928269(A) | 1999-07-01 | Alt | Applicant |
| US5928270(A) | 1999-07-01 | Ramsey, III | Applicant |
| US6002955(A) | 1999-12-01 | Willems et al. | Applicant |
| US6006131(A) | 1999-12-01 | Cooper et al. | Applicant |
| US6009351(A) | 1999-12-01 | Flachman | Applicant |
| US6014579(A) | 2000-01-01 | Pomeranz et al. | Applicant |
| US6029671(A) | 2000-02-01 | Stevens et al. | Applicant |
| US6033403(A) | 2000-03-01 | Tu et al. | Applicant |
| US6035238(A) | 2000-03-01 | Ingle | Examiner |
| US6045550(A) | 2000-04-01 | Simpson et al. | Applicant |
| US6068653(A) | 2000-05-01 | LaFontaine | Applicant |
| US6071274(A) | 2000-06-01 | Thompson et al. | Applicant |
| US6071281(A) | 2000-06-01 | Burnside et al. | Applicant |
| US6074389(A) | 2000-06-01 | Levine et al. | Applicant |
| US6076012(A) | 2000-06-01 | Swanson et al. | Applicant |
| US6090104(A) | 2000-07-01 | Webster, Jr. | Applicant |
| US6096036(A) | 2000-08-01 | Bowe et al. | Applicant |
| US6113595(A) | 2000-09-01 | Muntermann | Applicant |
| US6119041(A) | 2000-09-01 | Pomeranz et al. | Applicant |
| US6120500(A) | 2000-09-01 | Bednarek et al. | Applicant |
| US6146381(A) | 2000-11-01 | Bowe et al. | Applicant |
| US6164283(A) | 2000-12-01 | Lesh | Applicant |
| US6167291(A) | 2000-12-01 | Barajas et al. | Applicant |
| US6171305(B1) | 2001-01-01 | Sherman | Applicant |
| US6216034(B1) | 2001-04-01 | Hofmann et al. | Applicant |
| US6219582(B1) | 2001-04-01 | Hofstad et al. | Applicant |
| US6223085(B1) | 2001-04-01 | Dann et al. | Applicant |
| US6231518(B1) | 2001-05-01 | Grabek et al. | Applicant |
| US6245064(B1) | 2001-06-01 | Lesh et al. | Applicant |
| US6251107(B1) | 2001-06-01 | Schaer | Applicant |
| US6251128(B1) | 2001-06-01 | Knopp et al. | Applicant |
| US6270476(B1) | 2001-08-01 | Santoianni et al. | Applicant |
| US6272384(B1) | 2001-08-01 | Simon et al. | Applicant |
| US6287306(B1) | 2001-09-01 | Kroll et al. | Applicant |
| US6314963(B1) | 2001-11-01 | Vaska et al. | Applicant |
| US6322559(B1) | 2001-11-01 | Daulton et al. | Applicant |
| US6350263(B1) | 2002-02-01 | Wetzig et al. | Applicant |
| US6370412(B1) | 2002-04-01 | Armoundas et al. | Applicant |
| US6391024(B1) | 2002-05-01 | Sun et al. | Applicant |
| US6447505(B2) | 2002-09-01 | McGovern et al. | Applicant |
| US6464699(B1) | 2002-10-01 | Swanson | Applicant |
| US6470211(B1) | 2002-10-01 | Ideker et al. | Applicant |
| US6502576(B1) | 2003-01-01 | Lesh | Applicant |
| US6503247(B2) | 2003-01-01 | Swartz et al. | Applicant |
| US6517534(B1) | 2003-02-01 | McGovern et al. | Applicant |
| US6527724(B1) | 2003-03-01 | Fenici | Applicant |
| US6527767(B2) | 2003-03-01 | Wang et al. | Applicant |
| US6592581(B2) | 2003-07-01 | Bowe | Applicant |
| US6595991(B2) | 2003-07-01 | Toellner et al. | Applicant |
| US6607520(B2) | 2003-08-01 | Keane | Applicant |
| US6623480(B1) | 2003-09-01 | Kuo et al. | Applicant |
| US6638278(B2) | 2003-10-01 | Falwell et al. | Applicant |
| US6666863(B2) | 2003-12-01 | Wentzel et al. | Applicant |
| US6669693(B2) | 2003-12-01 | Friedman | Applicant |
| US6702811(B2) | 2004-03-01 | Stewart et al. | Applicant |
| US6719756(B1) | 2004-04-01 | Muntermann | Applicant |
| US6723092(B2) | 2004-04-01 | Brown et al. | Applicant |
| US6728563(B2) | 2004-04-01 | Rashidi | Applicant |
| US6743225(B2) | 2004-06-01 | Sanchez et al. | Applicant |
| US6743226(B2) | 2004-06-01 | Cosman et al. | Applicant |
| US6743239(B1) | 2004-06-01 | Kuehn et al. | Applicant |
| US6764486(B2) | 2004-07-01 | Natale | Applicant |
| US6780181(B2) | 2004-08-01 | Kroll et al. | Applicant |
| US6805128(B1) | 2004-10-01 | Pless et al. | Applicant |
| US6807447(B2) | 2004-10-01 | Griffin, III | Applicant |
| US6892091(B1) | 2005-05-01 | Ben-Haim et al. | Applicant |
| US6893438(B2) | 2005-05-01 | Hall et al. | Applicant |
| US6926714(B1) | 2005-08-01 | Sra | Applicant |
| US6955173(B2) | 2005-10-01 | Lesh | Applicant |
| US6960206(B2) | 2005-11-01 | Keane | Applicant |
| US6960207(B2) | 2005-11-01 | Vanney et al. | Applicant |
| US6972016(B2) | 2005-12-01 | Hill et al. | Applicant |
| US6973339(B2) | 2005-12-01 | Govari | Applicant |
| US6979331(B2) | 2005-12-01 | Hintringer et al. | Applicant |
| US6984232(B2) | 2006-01-01 | Vanney et al. | Applicant |
| US6985776(B2) | 2006-01-01 | Kane et al. | Applicant |
| US7001383(B2) | 2006-02-01 | Keidar | Applicant |
| US7041095(B2) | 2006-05-01 | Wang et al. | Applicant |
| US7113831(B2) | 2006-09-01 | Hooven | Applicant |
| US7171263(B2) | 2007-01-01 | Darvish et al. | Applicant |
| US7182725(B2) | 2007-02-01 | Bonan et al. | Applicant |
| US7195628(B2) | 2007-03-01 | Falkenberg | Applicant |
| US7207988(B2) | 2007-04-01 | Leckrone et al. | Applicant |
| US7207989(B2) | 2007-04-01 | Pike et al. | Applicant |
| US7229402(B2) | 2007-06-01 | Diaz et al. | Applicant |
| US7229437(B2) | 2007-06-01 | Johnson et al. | Applicant |
| US7250049(B2) | 2007-07-01 | Roop et al. | Applicant |
| US7282057(B2) | 2007-10-01 | Surti et al. | Applicant |
| US7285116(B2) | 2007-10-01 | De et al. | Applicant |
| US7285119(B2) | 2007-10-01 | Stewart et al. | Applicant |
| US7326208(B2) | 2008-02-01 | Vanney et al. | Applicant |
| US7346379(B2) | 2008-03-01 | Eng et al. | Applicant |
| US7367974(B2) | 2008-05-01 | Haemmerich et al. | Applicant |
| US7374567(B2) | 2008-05-01 | Heuser | Applicant |
| US7387629(B2) | 2008-06-01 | Vanney et al. | Applicant |
| US7387630(B2) | 2008-06-01 | Mest | Applicant |
| US7387636(B2) | 2008-06-01 | Cohn et al. | Applicant |
| US7416552(B2) | 2008-08-01 | Paul et al. | Applicant |
| US7419477(B2) | 2008-09-01 | Simpson et al. | Applicant |
| US7419489(B2) | 2008-09-01 | Vanney et al. | Applicant |
| US7422591(B2) | 2008-09-01 | Phan | Applicant |
| US7429261(B2) | 2008-09-01 | Kunis et al. | Applicant |
| US7435248(B2) | 2008-10-01 | Taimisto et al. | Applicant |
| US7513896(B2) | 2009-04-01 | Orszulak | Applicant |
| US7527625(B2) | 2009-05-01 | Knight et al. | Applicant |
| US7578816(B2) | 2009-08-01 | Boveja et al. | Applicant |
| US7588567(B2) | 2009-09-01 | Boveja et al. | Applicant |
| US7623899(B2) | 2009-11-01 | Worley et al. | Applicant |
| US7678108(B2) | 2010-03-01 | Chrisitian et al. | Applicant |
| US7681579(B2) | 2010-03-01 | Schwartz | Applicant |
| US7731717(B2) | 2010-06-01 | Odom | Examiner |
| US7771421(B2) | 2010-08-01 | Stewart et al. | Applicant |
| US7805182(B2) | 2010-09-01 | Weese et al. | Applicant |
| US7850642(B2) | 2010-12-01 | Moll et al. | Applicant |
| US7850685(B2) | 2010-12-01 | Kunis et al. | Applicant |
| US7857808(B2) | 2010-12-01 | Oral et al. | Applicant |
| US7857809(B2) | 2010-12-01 | Drysen | Applicant |
| US7869865(B2) | 2011-01-01 | Govari et al. | Applicant |
| US7896873(B2) | 2011-03-01 | Hiller et al. | Applicant |
| US7917211(B2) | 2011-03-01 | Zacouto | Applicant |
| US7918819(B2) | 2011-04-01 | Karmarkar et al. | Applicant |
| US7918850(B2) | 2011-04-01 | Govari et al. | Applicant |
| US7922714(B2) | 2011-04-01 | Stevens-Wright | Applicant |
| US7955827(B2) | 2011-06-01 | Rubinsky et al. | Applicant |
| US8048067(B2) | 2011-11-01 | Davalos et al. | Applicant |
| US8048072(B2) | 2011-11-01 | Verin et al. | Applicant |
| US8100895(B2) | 2012-01-01 | Panos et al. | Applicant |
| US8100900(B2) | 2012-01-01 | Prinz et al. | Applicant |
| US8108069(B2) | 2012-01-01 | Stahler et al. | Applicant |
| US8133220(B2) | 2012-03-01 | Lee et al. | Applicant |
| US8137342(B2) | 2012-03-01 | Crossman | Applicant |
| US8145289(B2) | 2012-03-01 | Calabro' et al. | Applicant |
| US8147486(B2) | 2012-04-01 | Honour et al. | Applicant |
| US8160690(B2) | 2012-04-01 | Wilfley et al. | Applicant |
| US8175680(B2) | 2012-05-01 | Panescu | Applicant |
| US8182477(B2) | 2012-05-01 | Orszulak et al. | Applicant |
| US8206384(B2) | 2012-06-01 | Falwell et al. | Applicant |
| US8206385(B2) | 2012-06-01 | Stangenes et al. | Applicant |
| US8216221(B2) | 2012-07-01 | Ibrahim et al. | Applicant |
| US8221411(B2) | 2012-07-01 | Francischelli et al. | Applicant |
| US8226648(B2) | 2012-07-01 | Paul et al. | Applicant |
| US8228065(B2) | 2012-07-01 | Wirtz et al. | Applicant |
| US8235986(B2) | 2012-08-01 | Kulesa et al. | Applicant |
| US8235988(B2) | 2012-08-01 | Davis et al. | Applicant |
| US8251986(B2) | 2012-08-01 | Chornenky et al. | Applicant |
| US8282631(B2) | 2012-10-01 | Davalos et al. | Applicant |
| US8287532(B2) | 2012-10-01 | Carroll et al. | Applicant |
| US8414508(B2) | 2013-04-01 | Thapliyal et al. | Applicant |
| US8430875(B2) | 2013-04-01 | Ibrahim et al. | Applicant |
| US8433394(B2) | 2013-04-01 | Harlev et al. | Applicant |
| US8449535(B2) | 2013-05-01 | Deno et al. | Applicant |
| US8454594(B2) | 2013-06-01 | Demarais et al. | Applicant |
| US8463368(B2) | 2013-06-01 | Harlev et al. | Applicant |
| US8475450(B2) | 2013-07-01 | Govari et al. | Applicant |
| US8486063(B2) | 2013-07-01 | Werneth et al. | Applicant |
| US8500733(B2) | 2013-08-01 | Watson | Applicant |
| US8535304(B2) | 2013-09-01 | Sklar et al. | Applicant |
| US8538501(B2) | 2013-09-01 | Venkatachalam et al. | Applicant |
| US8562588(B2) | 2013-10-01 | Hobbs et al. | Applicant |
| US8568406(B2) | 2013-10-01 | Harlev et al. | Applicant |
| US8568410(B2) | 2013-10-01 | Vakharia et al. | Applicant |
| US8571635(B2) | 2013-10-01 | Mcgee | Applicant |
| US8571647(B2) | 2013-10-01 | Harlev et al. | Applicant |
| US8579897(B2) | 2013-11-01 | Vakharia et al. | Applicant |
| US8585695(B2) | 2013-11-01 | Shih | Applicant |
| US8588885(B2) | 2013-11-01 | Hall et al. | Applicant |
| US8597288(B2) | 2013-12-01 | Christian | Applicant |
| US8608735(B2) | 2013-12-01 | Govari et al. | Applicant |
| US8628522(B2) | 2014-01-01 | Ibrahim et al. | Applicant |
| US8632534(B2) | 2014-01-01 | Pearson et al. | Applicant |
| US8647338(B2) | 2014-02-01 | Chornenky et al. | Applicant |
| US8708952(B2) | 2014-04-01 | Cohen et al. | Applicant |
| US8734442(B2) | 2014-05-01 | Cao et al. | Applicant |
| US8771267(B2) | 2014-07-01 | Kunis et al. | Applicant |
| US8795310(B2) | 2014-08-01 | Fung et al. | Applicant |
| US8808273(B2) | 2014-08-01 | Caples et al. | Applicant |
| US8808281(B2) | 2014-08-01 | Emmons et al. | Applicant |
| US8834461(B2) | 2014-09-01 | Werneth et al. | Applicant |
| US8834464(B2) | 2014-09-01 | Stewart et al. | Applicant |
| US8868169(B2) | 2014-10-01 | Narayan et al. | Applicant |
| US8876817(B2) | 2014-11-01 | Avitall et al. | Applicant |
| US8880195(B2) | 2014-11-01 | Azure | Applicant |
| US8886309(B2) | 2014-11-01 | Luther et al. | Applicant |
| US8903488(B2) | 2014-12-01 | Callas et al. | Applicant |
| US8920411(B2) | 2014-12-01 | Gelbart et al. | Applicant |
| US8926589(B2) | 2015-01-01 | Govari | Applicant |
| US8932287(B2) | 2015-01-01 | Gelbart et al. | Applicant |
| US8945117(B2) | 2015-02-01 | Bencini | Applicant |
| US8979841(B2) | 2015-03-01 | Kunis et al. | Applicant |
| US8986278(B2) | 2015-03-01 | Fung et al. | Applicant |
| US9002442(B2) | 2015-04-01 | Harley et al. | Applicant |
| US9005189(B2) | 2015-04-01 | Davalos et al. | Applicant |
| US9005194(B2) | 2015-04-01 | Oral et al. | Applicant |
| US9011425(B2) | 2015-04-01 | Fischer et al. | Applicant |
| US9044245(B2) | 2015-06-01 | Condie et al. | Applicant |
| US9055959(B2) | 2015-06-01 | Vaska et al. | Applicant |
| US9072518(B2) | 2015-07-01 | Swanson | Applicant |
| US9078667(B2) | 2015-07-01 | Besser et al. | Applicant |
| US9101374(B1) | 2015-08-01 | Hoch et al. | Applicant |
| US9119533(B2) | 2015-09-01 | Ghaffari | Applicant |
| US9119634(B2) | 2015-09-01 | Gelbart et al. | Applicant |
| US9131897(B2) | 2015-09-01 | Harada et al. | Applicant |
| US9155590(B2) | 2015-10-01 | Mathur | Applicant |
| US9162037(B2) | 2015-10-01 | Belson et al. | Applicant |
| US9179972(B2) | 2015-11-01 | Olson | Applicant |
| US9186481(B2) | 2015-11-01 | Avitall et al. | Applicant |
| US9192769(B2) | 2015-11-01 | Donofrio et al. | Applicant |
| US9211405(B2) | 2015-12-01 | Mahapatra et al. | Applicant |
| US9216055(B2) | 2015-12-01 | Spence et al. | Applicant |
| US9233248(B2) | 2016-01-01 | Luther et al. | Applicant |
| US9237926(B2) | 2016-01-01 | Nollert et al. | Applicant |
| US9262252(B2) | 2016-02-01 | Kirkpatrick et al. | Applicant |
| US9277957(B2) | 2016-03-01 | Long et al. | Applicant |
| US9282910(B2) | 2016-03-01 | Narayan et al. | Applicant |
| US9289258(B2) | 2016-03-01 | Cohen | Applicant |
| US9289606(B2) | 2016-03-01 | Paul et al. | Applicant |
| US9295516(B2) | 2016-03-01 | Pearson et al. | Applicant |
| US9301801(B2) | 2016-04-01 | Scheib | Applicant |
| US9375268(B2) | 2016-06-01 | Long | Applicant |
| US9414881(B2) | 2016-08-01 | Callas et al. | Applicant |
| US9468495(B2) | 2016-10-01 | Kunis et al. | Applicant |
| US9474486(B2) | 2016-10-01 | Eliason et al. | Applicant |
| US9474574(B2) | 2016-10-01 | Ibrahim et al. | Applicant |
| US9480525(B2) | 2016-11-01 | Lopes et al. | Applicant |
| US9486272(B2) | 2016-11-01 | Bonyak et al. | Applicant |
| US9486273(B2) | 2016-11-01 | Lopes et al. | Applicant |
| US9492227(B2) | 2016-11-01 | Lopes et al. | Applicant |
| US9492228(B2) | 2016-11-01 | Lopes et al. | Applicant |
| US9517103(B2) | 2016-12-01 | Panescu et al. | Applicant |
| US9526573(B2) | 2016-12-01 | Lopes et al. | Applicant |
| US9532831(B2) | 2017-01-01 | Reinders et al. | Applicant |
| US9539010(B2) | 2017-01-01 | Gagner et al. | Applicant |
| US9554848(B2) | 2017-01-01 | Stewart et al. | Applicant |
| US9554851(B2) | 2017-01-01 | Sklar et al. | Applicant |
| US9700368(B2) | 2017-07-01 | Callas et al. | Applicant |
| US9724170(B2) | 2017-08-01 | Mickelsen | Applicant |
| US9757193(B2) | 2017-09-01 | Zarins et al. | Applicant |
| US9782099(B2) | 2017-10-01 | Williams et al. | Applicant |
| US9795442(B2) | 2017-10-01 | Salahieh et al. | Applicant |
| US9861802(B2) | 2018-01-01 | Mickelsen | Applicant |
| US9913685(B2) | 2018-03-01 | Clark et al. | Applicant |
| US9931487(B2) | 2018-04-01 | Quinn et al. | Applicant |
| US9987081(B1) | 2018-06-01 | Bowers et al. | Applicant |
| US9999465(B2) | 2018-06-01 | Long et al. | Applicant |
| US10016232(B1) | 2018-07-01 | Bowers et al. | Applicant |
| US10117707(B2) | 2018-11-01 | Garcia et al. | Applicant |
| US10130423(B1) | 2018-11-01 | Viswanathan et al. | Applicant |
| US10136942(B1) | 2018-11-01 | Cosman et al. | Applicant |
| US10172673(B2) | 2019-01-01 | Viswanathan et al. | Applicant |
| US10292755(B2) | 2019-05-01 | Arena et al. | Applicant |
| US10322286(B2) | 2019-06-01 | Viswanathan et al. | Applicant |
| US10433906(B2) | 2019-10-01 | Mickelsen | Applicant |
| US10433908(B2) | 2019-10-01 | Viswanathan et al. | Applicant |
| US10448989(B2) | 2019-10-01 | Arena et al. | Applicant |
| US10507302(B2) | 2019-12-01 | Leeflang et al. | Applicant |
| US10512505(B2) | 2019-12-01 | Viswanathan | Applicant |
| US10512779(B2) | 2019-12-01 | Viswanathan et al. | Applicant |
| US10517672(B2) | 2019-12-01 | Long | Applicant |
| US10555769(B2) | 2020-02-01 | Worrell et al. | Applicant |
| US10624693(B2) | 2020-04-01 | Mickelsen et al. | Applicant |
| US2001/0000791(A1) | 2001-05-01 | Suorsa et al. | Applicant |
| US2001/0007070(A1) | 2001-07-01 | Stewart et al. | Applicant |
| US2001/0044624(A1) | 2001-11-01 | Seraj et al. | Applicant |
| US2002/0052602(A1) | 2002-05-01 | Wang et al. | Applicant |
| US2002/0077627(A1) | 2002-06-01 | Johnson et al. | Applicant |
| US2002/0087169(A1) | 2002-07-01 | Brock et al. | Applicant |
| US2002/0091384(A1) | 2002-07-01 | Hooven et al. | Applicant |
| US2002/0095176(A1) | 2002-07-01 | Prestel | Applicant |
| US2002/0111618(A1) | 2002-08-01 | Stewart et al. | Applicant |
| US2002/0156526(A1) | 2002-10-01 | Hlavka et al. | Applicant |
| US2002/0161323(A1) | 2002-10-01 | Miller et al. | Applicant |
| US2002/0169445(A1) | 2002-11-01 | Jain et al. | Applicant |
| US2002/0177765(A1) | 2002-11-01 | Bowe et al. | Applicant |
| US2002/0183638(A1) | 2002-12-01 | Swanson | Applicant |
| US2003/0014098(A1) | 2003-01-01 | Quijano et al. | Applicant |
| US2003/0018374(A1) | 2003-01-01 | Paulos | Applicant |
| US2003/0023287(A1) | 2003-01-01 | Edwards et al. | Applicant |
| US2003/0028189(A1) | 2003-02-01 | Woloszko et al. | Applicant |
| US2003/0050637(A1) | 2003-03-01 | Maguire et al. | Applicant |
| US2003/0114849(A1) | 2003-06-01 | Ryan | Applicant |
| US2003/0125729(A1) | 2003-07-01 | Hooven et al. | Applicant |
| US2003/0130598(A1) | 2003-07-01 | Manning et al. | Applicant |
| US2003/0130711(A1) | 2003-07-01 | Pearson et al. | Applicant |
| US2003/0204161(A1) | 2003-10-01 | Ferek-Petric | Applicant |
| US2003/0229379(A1) | 2003-12-01 | Ramsey | Applicant |
| US2004/0039382(A1) | 2004-02-01 | Kroll et al. | Applicant |
| US2004/0049181(A1) | 2004-03-01 | Stewart et al. | Applicant |
| US2004/0049182(A1) | 2004-03-01 | Koblish et al. | Applicant |
| US2004/0082859(A1) | 2004-04-01 | Schaer | Applicant |
| US2004/0082948(A1) | 2004-04-01 | Stewart et al. | Applicant |
| US2004/0087939(A1) | 2004-05-01 | Eggers et al. | Applicant |
| US2004/0111087(A1) | 2004-06-01 | Stern et al. | Applicant |
| US2004/0199157(A1) | 2004-10-01 | Palanker et al. | Applicant |
| US2004/0215139(A1) | 2004-10-01 | Cohen | Applicant |
| US2004/0231683(A1) | 2004-11-01 | Eng et al. | Applicant |
| US2004/0236360(A1) | 2004-11-01 | Cohn et al. | Applicant |
| US2004/0254607(A1) | 2004-12-01 | Wittenberger et al. | Applicant |
| US2004/0267337(A1) | 2004-12-01 | Hayzelden | Applicant |
| US2005/0033282(A1) | 2005-02-01 | Hooven | Applicant |
| US2005/0187545(A1) | 2005-08-01 | Hooven et al. | Applicant |
| US2005/0222632(A1) | 2005-10-01 | Obino | Applicant |
| US2005/0251130(A1) | 2005-11-01 | Boveja et al. | Applicant |
| US2005/0261672(A1) | 2005-11-01 | Deem et al. | Applicant |
| US2006/0009755(A1) | 2006-01-01 | Sra | Applicant |
| US2006/0009759(A1) | 2006-01-01 | Chrisitian et al. | Applicant |
| US2006/0015095(A1) | 2006-01-01 | Desinger et al. | Applicant |
| US2006/0015165(A1) | 2006-01-01 | Bertolero et al. | Applicant |
| US2006/0024359(A1) | 2006-02-01 | Walker et al. | Applicant |
| US2006/0058781(A1) | 2006-03-01 | Long | Applicant |
| US2006/0111702(A1) | 2006-05-01 | Oral et al. | Applicant |
| US2006/0142801(A1) | 2006-06-01 | Demarais et al. | Applicant |
| US2006/0167448(A1) | 2006-07-01 | Kozel | Applicant |
| US2006/0217703(A1) | 2006-09-01 | Chornenky et al. | Applicant |
| US2006/0241734(A1) | 2006-10-01 | Marshall et al. | Applicant |
| US2006/0264752(A1) | 2006-11-01 | Rubinsky et al. | Applicant |
| US2006/0270900(A1) | 2006-11-01 | Chin et al. | Applicant |
| US2006/0287648(A1) | 2006-12-01 | Schwartz | Applicant |
| US2006/0293730(A1) | 2006-12-01 | Rubinsky et al. | Applicant |
| US2006/0293731(A1) | 2006-12-01 | Rubinsky et al. | Applicant |
| US2007/0005053(A1) | 2007-01-01 | Dando | Applicant |
| US2007/0021744(A1) | 2007-01-01 | Creighton | Applicant |
| US2007/0060989(A1) | 2007-03-01 | Deem et al. | Applicant |
| US2007/0066972(A1) | 2007-03-01 | Ormsby et al. | Applicant |
| US2007/0129721(A1) | 2007-06-01 | Phan et al. | Applicant |
| US2007/0129760(A1) | 2007-06-01 | Demarais et al. | Applicant |
| US2007/0156135(A1) | 2007-07-01 | Rubinsky et al. | Applicant |
| US2007/0167740(A1) | 2007-07-01 | Grunewald et al. | Applicant |
| US2007/0167940(A1) | 2007-07-01 | Stevens-Wright | Applicant |
| US2007/0173878(A1) | 2007-07-01 | Heuser | Applicant |
| US2007/0208329(A1) | 2007-09-01 | Ward et al. | Applicant |
| US2007/0225589(A1) | 2007-09-01 | Viswanathan | Applicant |
| US2007/0249923(A1) | 2007-10-01 | Keenan | Applicant |
| US2007/0260223(A1) | 2007-11-01 | Scheibe et al. | Applicant |
| US2007/0270792(A1) | 2007-11-01 | Hennemann et al. | Applicant |
| US2008/0009855(A1) | 2008-01-01 | Hamou | Applicant |
| US2008/0033426(A1) | 2008-02-01 | Machell | Applicant |
| US2008/0065061(A1) | 2008-03-01 | Viswanathan | Applicant |
| US2008/0086120(A1) | 2008-04-01 | Mirza et al. | Applicant |
| US2008/0091195(A1) | 2008-04-01 | Sliwa et al. | Applicant |
| US2008/0103545(A1) | 2008-05-01 | Bolea et al. | Applicant |
| US2008/0132885(A1) | 2008-06-01 | Rubinsky et al. | Applicant |
| US2008/0161789(A1) | 2008-07-01 | Thao et al. | Applicant |
| US2008/0172048(A1) | 2008-07-01 | Martin | Examiner |
| US2008/0200913(A1) | 2008-08-01 | Viswanathan | Applicant |
| US2008/0208118(A1) | 2008-08-01 | Goldman | Applicant |
| US2008/0243214(A1) | 2008-10-01 | Koblish | Applicant |
| US2008/0281322(A1) | 2008-11-01 | Sherman et al. | Applicant |
| US2008/0300574(A1) | 2008-12-01 | Belson et al. | Applicant |
| US2008/0300588(A1) | 2008-12-01 | Groth et al. | Applicant |
| US2009/0024084(A1) | 2009-01-01 | Khosla et al. | Applicant |
| US2009/0048591(A1) | 2009-02-01 | Ibrahim et al. | Applicant |
| US2009/0062788(A1) | 2009-03-01 | Long et al. | Applicant |
| US2009/0062792(A1) | 2009-03-01 | Vakharia et al. | Applicant |
| US2009/0076500(A1) | 2009-03-01 | Azure | Applicant |
| US2009/0105654(A1) | 2009-04-01 | Kurth et al. | Applicant |
| US2009/0138009(A1) | 2009-05-01 | Viswanathan et al. | Applicant |
| US2009/0149917(A1) | 2009-06-01 | Whitehurst et al. | Applicant |
| US2009/0163905(A1) | 2009-06-01 | Winkler et al. | Applicant |
| US2009/0228003(A1) | 2009-09-01 | Sinelnikov | Applicant |
| US2009/0240248(A1) | 2009-09-01 | Deford et al. | Applicant |
| US2009/0275827(A1) | 2009-11-01 | Aiken et al. | Applicant |
| US2009/0281477(A1) | 2009-11-01 | Mikus et al. | Applicant |
| US2009/0306651(A1) | 2009-12-01 | Schneider | Applicant |
| US2010/0004623(A1) | 2010-01-01 | Hamilton et al. | Applicant |
| US2010/0023004(A1) | 2010-01-01 | Francischelli et al. | Applicant |
| US2010/0137861(A1) | 2010-06-01 | Soroff et al. | Applicant |
| US2010/0185140(A1) | 2010-07-01 | Kassab et al. | Applicant |
| US2010/0185186(A1) | 2010-07-01 | Longoria | Applicant |
| US2010/0191112(A1) | 2010-07-01 | Demarais et al. | Applicant |
| US2010/0191232(A1) | 2010-07-01 | Boveda | Applicant |
| US2010/0241185(A1) | 2010-09-01 | Mahapatra et al. | Applicant |
| US2010/0261994(A1) | 2010-10-01 | Davalos et al. | Applicant |
| US2010/0274238(A1) | 2010-10-01 | Klimovitch | Applicant |
| US2010/0280513(A1) | 2010-11-01 | Juergen et al. | Applicant |
| US2010/0280539(A1) | 2010-11-01 | Miyoshi et al. | Applicant |
| US2010/0292687(A1) | 2010-11-01 | Kauphusman et al. | Applicant |
| US2010/0312096(A1) | 2010-12-01 | Guttman et al. | Applicant |
| US2010/0312300(A1) | 2010-12-01 | Ryu et al. | Applicant |
| US2011/0028962(A1) | 2011-02-01 | Werneth et al. | Applicant |
| US2011/0028964(A1) | 2011-02-01 | Edwards | Applicant |
| US2011/0040199(A1) | 2011-02-01 | Hopenfeld | Applicant |
| US2011/0098694(A1) | 2011-04-01 | Long | Applicant |
| US2011/0106221(A1) | 2011-05-01 | Neal et al. | Applicant |
| US2011/0130708(A1) | 2011-06-01 | Perry et al. | Applicant |
| US2011/0144524(A1) | 2011-06-01 | Fish et al. | Applicant |
| US2011/0144633(A1) | 2011-06-01 | Govari | Applicant |
| US2011/0160785(A1) | 2011-06-01 | Mori et al. | Applicant |
| US2011/0190659(A1) | 2011-08-01 | Long et al. | Applicant |
| US2011/0190727(A1) | 2011-08-01 | Edmunds et al. | Applicant |
| US2011/0208185(A1) | 2011-08-01 | Diamant et al. | Applicant |
| US2011/0213231(A1) | 2011-09-01 | Hall et al. | Applicant |
| US2011/0276047(A1) | 2011-11-01 | Sklar et al. | Applicant |
| US2011/0276075(A1) | 2011-11-01 | Fung et al. | Applicant |
| US2011/0288544(A1) | 2011-11-01 | Verin et al. | Applicant |
| US2011/0288547(A1) | 2011-11-01 | Morgan et al. | Applicant |
| US2011/0313417(A1) | 2011-12-01 | De et al. | Applicant |
| US2012/0029512(A1) | 2012-02-01 | Willard et al. | Applicant |
| US2012/0046570(A1) | 2012-02-01 | Villegas et al. | Applicant |
| US2012/0053581(A1) | 2012-03-01 | Wittkampf et al. | Applicant |
| US2012/0059255(A1) | 2012-03-01 | Paul et al. | Applicant |
| US2012/0071872(A1) | 2012-03-01 | Rubinsky et al. | Applicant |
| US2012/0078343(A1) | 2012-03-01 | Fish | Applicant |
| US2012/0089089(A1) | 2012-04-01 | Swain et al. | Applicant |
| US2012/0095459(A1) | 2012-04-01 | Callas et al. | Applicant |
| US2012/0101413(A1) | 2012-04-01 | Beetel et al. | Applicant |
| US2012/0158021(A1) | 2012-06-01 | Morrill | Applicant |
| US2012/0165667(A1) | 2012-06-01 | Altmann et al. | Applicant |
| US2012/0172859(A1) | 2012-07-01 | Condie et al. | Applicant |
| US2012/0172867(A1) | 2012-07-01 | Ryu et al. | Applicant |
| US2012/0197100(A1) | 2012-08-01 | Razavi et al. | Applicant |
| US2012/0209260(A1) | 2012-08-01 | Lambert et al. | Applicant |
| US2012/0220998(A1) | 2012-08-01 | Long et al. | Applicant |
| US2012/0265198(A1) | 2012-10-01 | Crow et al. | Applicant |
| US2012/0283582(A1) | 2012-11-01 | Mahapatra et al. | Applicant |
| US2012/0303019(A1) | 2012-11-01 | Zhao et al. | Applicant |
| US2012/0310052(A1) | 2012-12-01 | Mahapatra et al. | Applicant |
| US2012/0310230(A1) | 2012-12-01 | Willis | Applicant |
| US2012/0310237(A1) | 2012-12-01 | Swanson | Applicant |
| US2012/0316557(A1) | 2012-12-01 | Sartor et al. | Applicant |
| US2013/0030430(A1) | 2013-01-01 | Stewart et al. | Applicant |
| US2013/0060247(A1) | 2013-03-01 | Sklar et al. | Applicant |
| US2013/0060248(A1) | 2013-03-01 | Sklar et al. | Applicant |
| US2013/0079768(A1) | 2013-03-01 | De et al. | Applicant |
| US2013/0090651(A1) | 2013-04-01 | Smith | Applicant |
| US2013/0096655(A1) | 2013-04-01 | Moffitt et al. | Applicant |
| US2013/0103027(A1) | 2013-04-01 | Sklar et al. | Applicant |
| US2013/0103064(A1) | 2013-04-01 | Arenson et al. | Applicant |
| US2013/0131662(A1) | 2013-05-01 | Wittkampf | Applicant |
| US2013/0158538(A1) | 2013-06-01 | Govari | Applicant |
| US2013/0158621(A1) | 2013-06-01 | Ding et al. | Applicant |
| US2013/0172715(A1) | 2013-07-01 | Just et al. | Applicant |
| US2013/0172864(A1) | 2013-07-01 | Ibrahim et al. | Applicant |
| US2013/0172875(A1) | 2013-07-01 | Govari et al. | Applicant |
| US2013/0184702(A1) | 2013-07-01 | Neal et al. | Applicant |
| US2013/0218157(A1) | 2013-08-01 | Callas et al. | Applicant |
| US2013/0226174(A1) | 2013-08-01 | Ibrahim et al. | Applicant |
| US2013/0237984(A1) | 2013-09-01 | Sklar | Applicant |
| US2013/0253415(A1) | 2013-09-01 | Sano et al. | Applicant |
| US2013/0296679(A1) | 2013-11-01 | Condie et al. | Applicant |
| US2013/0310829(A1) | 2013-11-01 | Cohen | Applicant |
| US2013/0317385(A1) | 2013-11-01 | Sklar et al. | Applicant |
| US2013/0331831(A1) | 2013-12-01 | Werneth et al. | Applicant |
| US2013/0338467(A1) | 2013-12-01 | Grasse et al. | Applicant |
| US2014/0005664(A1) | 2014-01-01 | Govari et al. | Applicant |
| US2014/0024911(A1) | 2014-01-01 | Harlev et al. | Applicant |
| US2014/0039288(A1) | 2014-02-01 | Hue-Teh | Applicant |
| US2014/0051993(A1) | 2014-02-01 | Mcgee | Applicant |
| US2014/0052118(A1) | 2014-02-01 | Laske et al. | Applicant |
| US2014/0052126(A1) | 2014-02-01 | Long et al. | Applicant |
| US2014/0052216(A1) | 2014-02-01 | Long et al. | Applicant |
| US2014/0058377(A1) | 2014-02-01 | Deem et al. | Applicant |
| US2014/0081113(A1) | 2014-03-01 | Cohen et al. | Applicant |
| US2014/0100563(A1) | 2014-04-01 | Govari et al. | Applicant |
| US2014/0107644(A1) | 2014-04-01 | Falwell et al. | Applicant |
| US2014/0142408(A1) | 2014-05-01 | De et al. | Applicant |
| US2014/0148804(A1) | 2014-05-01 | Ward et al. | Applicant |
| US2014/0163480(A1) | 2014-06-01 | Govari et al. | Applicant |
| US2014/0163546(A1) | 2014-06-01 | Govari et al. | Applicant |
| US2014/0171942(A1) | 2014-06-01 | Werneth et al. | Applicant |
| US2014/0180035(A1) | 2014-06-01 | Anderson | Applicant |
| US2014/0187916(A1) | 2014-07-01 | Clark et al. | Applicant |
| US2014/0194716(A1) | 2014-07-01 | Diep et al. | Applicant |
| US2014/0194867(A1) | 2014-07-01 | Fish et al. | Applicant |
| US2014/0200567(A1) | 2014-07-01 | Cox et al. | Applicant |
| US2014/0235986(A1) | 2014-08-01 | Harlev et al. | Applicant |
| US2014/0235988(A1) | 2014-08-01 | Ghosh | Applicant |
| US2014/0235989(A1) | 2014-08-01 | Wodlinger et al. | Applicant |
| US2014/0243851(A1) | 2014-08-01 | Cohen et al. | Applicant |
| US2014/0276760(A1) | 2014-09-01 | Bonyak et al. | Applicant |
| US2014/0276782(A1) | 2014-09-01 | Paskar | Applicant |
| US2014/0276791(A1) | 2014-09-01 | Ku et al. | Applicant |
| US2014/0288556(A1) | 2014-09-01 | Ibrahim et al. | Applicant |
| US2014/0303721(A1) | 2014-10-01 | Fung et al. | Applicant |
| US2014/0343549(A1) | 2014-11-01 | Spear et al. | Applicant |
| US2014/0364845(A1) | 2014-12-01 | Rashidi | Applicant |
| US2014/0371613(A1) | 2014-12-01 | Narayan et al. | Applicant |
| US2015/0005767(A1) | 2015-01-01 | Werneth et al. | Applicant |
| US2015/0011995(A1) | 2015-01-01 | Avitall et al. | Applicant |
| US2015/0066108(A1) | 2015-03-01 | Shi et al. | Applicant |
| US2015/0119674(A1) | 2015-04-01 | Fischell et al. | Applicant |
| US2015/0126840(A1) | 2015-05-01 | Thakur et al. | Applicant |
| US2015/0133914(A1) | 2015-05-01 | Koblish | Applicant |
| US2015/0138977(A1) | 2015-05-01 | Dacosta | Applicant |
| US2015/0141810(A1) | 2015-05-01 | Weadock | Examiner |
| US2015/0141978(A1) | 2015-05-01 | Subramaniam et al. | Applicant |
| US2015/0141982(A1) | 2015-05-01 | Lee | Applicant |
| US2015/0142041(A1) | 2015-05-01 | Kendale et al. | Applicant |
| US2015/0148796(A1) | 2015-05-01 | Bencini | Applicant |
| US2015/0150472(A1) | 2015-06-01 | Harlev et al. | Applicant |
| US2015/0157402(A1) | 2015-06-01 | Kunis et al. | Applicant |
| US2015/0157412(A1) | 2015-06-01 | Wallace et al. | Applicant |
| US2015/0164584(A1) | 2015-06-01 | Davalos et al. | Applicant |
| US2015/0173824(A1) | 2015-06-01 | Davalos et al. | Applicant |
| US2015/0173828(A1) | 2015-06-01 | Avitall | Applicant |
| US2015/0174404(A1) | 2015-06-01 | Rousso et al. | Applicant |
| US2015/0182740(A1) | 2015-07-01 | Mickelsen | Applicant |
| US2015/0196217(A1) | 2015-07-01 | Harlev et al. | Applicant |
| US2015/0223726(A1) | 2015-08-01 | Harlev et al. | Applicant |
| US2015/0230699(A1) | 2015-08-01 | Berul et al. | Applicant |
| US2015/0258344(A1) | 2015-09-01 | Tandri et al. | Applicant |
| US2015/0265342(A1) | 2015-09-01 | Long et al. | Applicant |
| US2015/0265344(A1) | 2015-09-01 | Aktas et al. | Applicant |
| US2015/0272656(A1) | 2015-10-01 | Chen | Applicant |
| US2015/0272664(A9) | 2015-10-01 | Cohen | Applicant |
| US2015/0272667(A1) | 2015-10-01 | Govari et al. | Applicant |
| US2015/0282729(A1) | 2015-10-01 | Harlev et al. | Applicant |
| US2015/0289923(A1) | 2015-10-01 | Davalos et al. | Applicant |
| US2015/0304879(A1) | 2015-10-01 | Dacosta | Applicant |
| US2015/0320481(A1) | 2015-11-01 | Cosman et al. | Applicant |
| US2015/0321021(A1) | 2015-11-01 | Tandri et al. | Applicant |
| US2015/0327944(A1) | 2015-11-01 | Neal et al. | Applicant |
| US2015/0342532(A1) | 2015-12-01 | Basu et al. | Applicant |
| US2015/0343212(A1) | 2015-12-01 | Rousso et al. | Applicant |
| US2015/0351836(A1) | 2015-12-01 | Prutchi | Applicant |
| US2015/0359583(A1) | 2015-12-01 | Swanson | Applicant |
| US2016/0000500(A1) | 2016-01-01 | Salahieh et al. | Applicant |
| US2016/0008061(A1) | 2016-01-01 | Fung et al. | Applicant |
| US2016/0008065(A1) | 2016-01-01 | Gliner et al. | Applicant |
| US2016/0029960(A1) | 2016-02-01 | Toth et al. | Applicant |
| US2016/0038772(A1) | 2016-02-01 | Thapliyal et al. | Applicant |
| US2016/0051204(A1) | 2016-02-01 | Harlev et al. | Applicant |
| US2016/0051324(A1) | 2016-02-01 | Stewart et al. | Applicant |
| US2016/0058493(A1) | 2016-03-01 | Neal et al. | Applicant |
| US2016/0058506(A1) | 2016-03-01 | Spence et al. | Applicant |
| US2016/0066993(A1) | 2016-03-01 | Avitall et al. | Applicant |
| US2016/0074679(A1) | 2016-03-01 | Thapliyal et al. | Applicant |
| US2016/0095531(A1) | 2016-04-01 | Narayan et al. | Applicant |
| US2016/0095642(A1) | 2016-04-01 | Deno et al. | Applicant |
| US2016/0095653(A1) | 2016-04-01 | Lambert et al. | Applicant |
| US2016/0100797(A1) | 2016-04-01 | Mahapatra et al. | Applicant |
| US2016/0100884(A1) | 2016-04-01 | Fay et al. | Applicant |
| US2016/0106498(A1) | 2016-04-01 | Highsmith et al. | Applicant |
| US2016/0106500(A1) | 2016-04-01 | Olson | Applicant |
| US2016/0113709(A1) | 2016-04-01 | Maor | Applicant |
| US2016/0113712(A1) | 2016-04-01 | Cheung et al. | Applicant |
| US2016/0120564(A1) | 2016-05-01 | Kirkpatrick et al. | Applicant |
| US2016/0128770(A1) | 2016-05-01 | Afonso et al. | Applicant |
| US2016/0166167(A1) | 2016-06-01 | Narayan et al. | Applicant |
| US2016/0166310(A1) | 2016-06-01 | Stewart et al. | Applicant |
| US2016/0166311(A1) | 2016-06-01 | Long et al. | Applicant |
| US2016/0174865(A1) | 2016-06-01 | Stewart et al. | Applicant |
| US2016/0183877(A1) | 2016-06-01 | Williams et al. | Applicant |
| US2016/0184003(A1) | 2016-06-01 | Srimathveeravalli et al. | Applicant |
| US2016/0184004(A1) | 2016-06-01 | Hull et al. | Applicant |
| US2016/0213282(A1) | 2016-07-01 | Leo et al. | Applicant |
| US2016/0220307(A1) | 2016-08-01 | Miller et al. | Applicant |
| US2016/0235470(A1) | 2016-08-01 | Callas et al. | Applicant |
| US2016/0287314(A1) | 2016-10-01 | Arena et al. | Applicant |
| US2016/0310211(A1) | 2016-10-01 | Long | Applicant |
| US2016/0324564(A1) | 2016-11-01 | Gerlach et al. | Applicant |
| US2016/0324573(A1) | 2016-11-01 | Mickelson et al. | Applicant |
| US2016/0331441(A1) | 2016-11-01 | Konings | Applicant |
| US2016/0331459(A1) | 2016-11-01 | Townley et al. | Applicant |
| US2016/0338770(A1) | 2016-11-01 | Bar-Tal et al. | Applicant |
| US2016/0354142(A1) | 2016-12-01 | Pearson et al. | Applicant |
| US2016/0361109(A1) | 2016-12-01 | Weaver et al. | Applicant |
| US2017/0001016(A1) | 2017-01-01 | De Ridder | Applicant |
| US2017/0035499(A1) | 2017-02-01 | Stewart et al. | Applicant |
| US2017/0042449(A1) | 2017-02-01 | Deno et al. | Applicant |
| US2017/0042615(A1) | 2017-02-01 | Salahieh et al. | Applicant |
| US2017/0056648(A1) | 2017-03-01 | Syed et al. | Applicant |
| US2017/0065330(A1) | 2017-03-01 | Mickelsen et al. | Applicant |
| US2017/0065339(A1) | 2017-03-01 | Mickelsen | Applicant |
| US2017/0065340(A1) | 2017-03-01 | Long | Applicant |
| US2017/0065343(A1) | 2017-03-01 | Mickelsen | Applicant |
| US2017/0071543(A1) | 2017-03-01 | Basu et al. | Applicant |
| US2017/0095291(A1) | 2017-04-01 | Harrington et al. | Applicant |
| US2017/0105793(A1) | 2017-04-01 | Cao et al. | Applicant |
| US2017/0120048(A1) | 2017-05-01 | He et al. | Applicant |
| US2017/0146584(A1) | 2017-05-01 | Daw et al. | Applicant |
| US2017/0151029(A1) | 2017-06-01 | Mickelsen | Applicant |
| US2017/0172654(A1) | 2017-06-01 | Wittkampf et al. | Applicant |
| US2017/0181795(A1) | 2017-06-01 | Debruyne | Applicant |
| US2017/0189097(A1) | 2017-07-01 | Viswanathan et al. | Applicant |
| US2017/0215953(A1) | 2017-08-01 | Long et al. | Applicant |
| US2017/0245928(A1) | 2017-08-01 | Xiao et al. | Applicant |
| US2017/0246455(A1) | 2017-08-01 | Athos et al. | Applicant |
| US2017/0312024(A1) | 2017-11-01 | Harlev et al. | Applicant |
| US2017/0312025(A1) | 2017-11-01 | Harlev et al. | Applicant |
| US2017/0312027(A1) | 2017-11-01 | Harlev et al. | Applicant |
| US2018/0001056(A1) | 2018-01-01 | Leeflang et al. | Applicant |
| US2018/0042674(A1) | 2018-02-01 | Mickelsen | Applicant |
| US2018/0042675(A1) | 2018-02-01 | Long | Applicant |
| US2018/0043153(A1) | 2018-02-01 | Viswanathan et al. | Applicant |
| US2018/0064488(A1) | 2018-03-01 | Long et al. | Applicant |
| US2018/0085160(A1) | 2018-03-01 | Viswanathan et al. | Applicant |
| US2018/0093088(A1) | 2018-04-01 | Mickelsen | Applicant |
| US2018/0133460(A1) | 2018-05-01 | Townley et al. | Applicant |
| US2018/0168511(A1) | 2018-06-01 | Hall et al. | Applicant |
| US2018/0184982(A1) | 2018-07-01 | Basu et al. | Applicant |
| US2018/0193090(A1) | 2018-07-01 | De et al. | Applicant |
| US2018/0200497(A1) | 2018-07-01 | Mickelsen | Applicant |
| US2018/0235496(A1) | 2018-08-01 | Wu et al. | Applicant |
| US2018/0280080(A1) | 2018-10-01 | Govari et al. | Applicant |
| US2018/0289417(A1) | 2018-10-01 | Schweitzer et al. | Applicant |
| US2018/0303488(A1) | 2018-10-01 | Hill | Applicant |
| US2018/0311497(A1) | 2018-11-01 | Viswanathan et al. | Applicant |
| US2018/0344202(A1) | 2018-12-01 | Bar-Tal et al. | Applicant |
| US2018/0344393(A1) | 2018-12-01 | Gruba et al. | Applicant |
| US2018/0360531(A1) | 2018-12-01 | Holmes et al. | Applicant |
| US2018/0360534(A1) | 2018-12-01 | Teplitsky et al. | Applicant |
| US2019/0015007(A1) | 2019-01-01 | Rottmann et al. | Applicant |
| US2019/0030328(A1) | 2019-01-01 | Stewart et al. | Applicant |
| US2019/0038171(A1) | 2019-02-01 | Howard | Applicant |
| US2019/0046791(A1) | 2019-02-01 | Ebbers et al. | Applicant |
| US2019/0069950(A1) | 2019-03-01 | Viswanathan et al. | Applicant |
| US2019/0125439(A1) | 2019-05-01 | Rohl et al. | Applicant |
| US2019/0151015(A1) | 2019-05-01 | Viswanathan et al. | Applicant |
| US2019/0175263(A1) | 2019-06-01 | Altmann et al. | Applicant |
| US2019/0183378(A1) | 2019-06-01 | Mosesov et al. | Applicant |
| US2019/0183567(A1) | 2019-06-01 | Govari et al. | Applicant |
| US2019/0209238(A1) | 2019-07-01 | Jimenez | Applicant |
| US2019/0223938(A1) | 2019-07-01 | Arena et al. | Applicant |
| US2019/0223948(A1) | 2019-07-01 | Stewart et al. | Applicant |
| US2019/0223950(A1) | 2019-07-01 | Gelbart et al. | Applicant |
| US2019/0231421(A1) | 2019-08-01 | Viswanathan et al. | Applicant |
| US2019/0233809(A1) | 2019-08-01 | Neal et al. | Applicant |
| US2019/0256839(A1) | 2019-08-01 | Neal et al. | Applicant |
| US2019/0269912(A1) | 2019-09-01 | Viswanathan et al. | Applicant |
| US2019/0328445(A1) | 2019-10-01 | Sano et al. | Applicant |
| US2019/0336198(A1) | 2019-11-01 | Viswanathan et al. | Applicant |
| US2019/0336207(A1) | 2019-11-01 | Viswanathan | Applicant |
| US2019/0350649(A1) | 2019-11-01 | Sutermeister et al. | Applicant |
| US2019/0376055(A1) | 2019-12-01 | Davalos et al. | Applicant |
| EP1042990(A1) | 2000-10-01 | Applicant | |
| EP1125549(A2) | 2001-08-01 | Applicant | |
| EP797956(B1) | 2003-06-01 | Applicant | |
| EP1340469(A1) | 2003-09-01 | Applicant | |
| EP1127552(B1) | 2006-06-01 | Applicant | |
| EP1803411(A2) | 2007-07-01 | Applicant | |
| EP1009303(B1) | 2009-06-01 | Applicant | |
| EP2213729(A2) | 2010-08-01 | Applicant | |
| EP2382935(A1) | 2011-11-01 | Applicant | |
| EP2425871(A2) | 2012-03-01 | Applicant | |
| EP2532320(A2) | 2012-12-01 | Applicant | |
| EP2587275(A1) | 2013-05-01 | Applicant | |
| EP2663227(A1) | 2013-11-01 | Applicant | |
| EP1909678(B1) | 2014-01-01 | Applicant | |
| EP2217165(B1) | 2014-03-01 | Applicant | |
| EP2376193(B1) | 2014-03-01 | Applicant | |
| EP2708181(A1) | 2014-03-01 | Applicant | |
| EP2777579(A1) | 2014-09-01 | Applicant | |
| EP2777585(A1) | 2014-09-01 | Applicant | |
| EP2934307(A1) | 2015-10-01 | Applicant | |
| EP3056242(A1) | 2016-08-01 | Applicant | |
| EP3111871(A1) | 2017-01-01 | Applicant | |
| EP3151773(B1) | 2018-04-01 | Applicant | |
| JP6-507797(A) | 1994-09-01 | Applicant | |
| JP10-510745(A) | 1998-10-01 | Applicant | |
| JP2000-508196(A) | 2000-07-01 | Applicant | |
| JP2005-516666(A) | 2005-06-01 | Applicant | |
| JP2006-506184(A) | 2006-02-01 | Applicant | |
| JP2006-507797(A) | 2006-03-01 | Applicant | |
| JP2007-325935(A) | 2007-12-01 | Applicant | |
| JP2008-538997(A) | 2008-11-01 | Applicant | |
| JP2009-500129(A) | 2009-01-01 | Applicant | |
| JP2010-510745(A) | 2010-04-01 | Applicant | |
| JP2011-509158(A) | 2011-03-01 | Applicant | |
| JP2012-050538(A) | 2012-03-01 | Applicant | |
| WO92/07622(A1) | 1992-05-01 | Applicant | |
| WO92/21278(A1) | 1992-12-01 | Applicant | |
| WO92/21285(A1) | 1992-12-01 | Applicant | |
| WO94/07413(A1) | 1994-04-01 | Applicant | |
| WO97/24073(A1) | 1997-07-01 | Applicant | |
| WO97/25917(A1) | 1997-07-01 | Applicant | |
| WO97/37719(A1) | 1997-10-01 | Applicant | |
| WO99/04851(A1) | 1999-02-01 | Applicant | |
| WO99/22659(A1) | 1999-05-01 | Applicant | |
| WO99/56650(A1) | 1999-11-01 | Applicant | |
| WO99/59486(A2) | 1999-11-01 | Applicant | |
| WO2/56782(A2) | 2002-07-01 | Applicant | |
| WO3/53289(A1) | 2003-07-01 | Applicant | |
| WO3/65916(A1) | 2003-08-01 | Applicant | |
| WO2004/045442(A1) | 2004-06-01 | Applicant | |
| WO2004/086994(A1) | 2004-10-01 | Applicant | |
| WO2005/046487(A1) | 2005-05-01 | Applicant | |
| WO2006/115902(A2) | 2006-11-01 | Applicant | |
| WO2007/006055(A2) | 2007-01-01 | Applicant | |
| WO2007/079438(A2) | 2007-07-01 | Applicant | |
| WO2009/082710(A1) | 2009-07-01 | Applicant | |
| WO2009/089343(A1) | 2009-07-01 | Applicant | |
| WO2009/137800(A2) | 2009-11-01 | Applicant | |
| WO2010/014480(A1) | 2010-02-01 | Applicant | |
| WO2011/028310(A1) | 2011-03-01 | Applicant | |
| WO2011/154805(A1) | 2011-12-01 | Applicant | |
| WO2012/051433(A2) | 2012-04-01 | Applicant | |
| WO2012/097067(A1) | 2012-07-01 | Applicant | |
| WO2012/153928(A2) | 2012-11-01 | Applicant | |
| WO2013/019385(A1) | 2013-02-01 | Applicant | |
| WO2014/008489(A1) | 2014-01-01 | Applicant | |
| WO2014/025394(A1) | 2014-02-01 | Applicant | |
| WO2014/031800(A1) | 2014-02-01 | Applicant | |
| WO2014/036439(A2) | 2014-03-01 | Applicant | |
| WO2014/100579(A1) | 2014-06-01 | Applicant | |
| WO2014/160832(A2) | 2014-10-01 | Applicant | |
| WO2015/066322(A1) | 2015-05-01 | Applicant | |
| WO2015/099786(A1) | 2015-07-01 | Applicant | |
| WO2015/103530(A1) | 2015-07-01 | Applicant | |
| WO2015/103574(A1) | 2015-07-01 | Applicant | |
| WO2015/130824(A1) | 2015-09-01 | Applicant | |
| WO2015/140741(A1) | 2015-09-01 | Applicant | |
| WO2015/143327(A1) | 2015-09-01 | Applicant | |
| WO2015/171921(A2) | 2015-11-01 | Applicant | |
| WO2015/175944(A1) | 2015-11-01 | Applicant | |
| WO2015/192018(A1) | 2015-12-01 | Applicant | |
| WO2015/192027(A1) | 2015-12-01 | Applicant | |
| WO2016/059027(A1) | 2016-04-01 | Applicant | |
| WO2016/060983(A1) | 2016-04-01 | Applicant | |
| WO2016/081650(A1) | 2016-05-01 | Applicant | |
| WO2016/090175(A1) | 2016-06-01 | Applicant | |
| WO2017/093926(A1) | 2017-06-01 | Applicant | |
| WO2017/119934(A1) | 2017-07-01 | Applicant | |
| WO2017/120169(A1) | 2017-07-01 | Applicant | |
| WO2017/192477(A1) | 2017-11-01 | Applicant | |
| WO2017/192495(A1) | 2017-11-01 | Applicant | |
| WO2017/201504(A1) | 2017-11-01 | Applicant | |
| WO2017/218734(A1) | 2017-12-01 | Applicant | |
| WO2018/005511(A1) | 2018-01-01 | Applicant | |
| WO2018/191149(A1) | 2018-10-01 | Applicant | |
| WO2018/200800(A1) | 2018-11-01 | Applicant | |
| WO2019/118436(A1) | 2019-06-01 | Applicant | |
| WO2019/133606(A1) | 2019-07-01 | Applicant | |
| WO2019/234133(A1) | 2019-12-01 | Applicant |
Non-Patent Literature (11)
- Du Pre, B.C. et al., “Minimal coronary artery damage by myocardial electroporation ablation,” Europace, 15(1):144-149 (2013).Applicant
- Hobbs, E. P., “Investor Relations Update: Tissue Ablation via Irreversible Electroporation (IRE),” Powerpoint (2004), 16 pages.Applicant
- Lavee, J. et al., “A Novel Nonthermal Energy Source for Surgical Epicardial Atrial Ablation: Irreversible Electroporation,” The Heart Surgery Forum #2006-1202, 10(2), 2007 [Epub Mar. 2007].Applicant
- Madhavan, M. et al., “Novel Percutaneous Epicardial Autonomic Modulation in the Canine for Atrial Fibrillation: Results of an Efficacy and Safety Study,” Pace, 00:1-11 (2016).Applicant
- Neven, K. et al., “Epicardial linear electroporation ablation and lesion size,” Heart Rhythm, 11:1465-1470 (2014).Applicant
- Neven, K. et al., “Myocardial Lesion Size After Epicardial Electroporation Catheter Ablation After Subxiphoid Puncture,” Circ Arrhythm Electrophysiol., 7(4):728-733 (2014).Applicant
- Neven, K. et al., “Safety and Feasibility of Closed Chest Epicardial Catheter Ablation Using Electroporation,” Circ Arrhythm Electrophysiol., 7:913-919 (2014).Applicant
- Van Driel, V.J.H.M. et al., “Low vulnerability of the right phrenic nerve to electroporation ablation,” Heart Rhythm, 12:1838-1844 (2015).Applicant
- Van Driel, V.J.H.M. et al., “Pulmonary Vein Stenosis After Catheter Ablation Electroporation Versus Radiofrequency,” Circ Arrhythm Electrophysiol., 7(4):734-738 (2014).Applicant
- Wittkampf, F.H. et al., “Feasibility of Electroporation for the Creation of Pulmonary Vein Ostial Lesions,” J Cardiovasc Electrophysiol, 22(3):302-309 (Mar. 2011).Applicant
- Wittkampf, F.H. et al., “Myocardial Lesion Depth With Circular Electroporation Ablation,” Circ. Arrhythm Electrophysiol., 5(3):581-586 (2012).Applicant